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Use of acronyms for sarcomas has been made: 
1. in tables and diagrams where necessitated by lack 
of space, although this has been minimised in Figs. 5 
to make them as self-contained as possible. 
2. in text sections where the unabbreviated form has 
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(The suffix -sarcoma has generally been omitted from tables 




The diagnosis by light microscopy of the malignant tumours 
of soft tissues known as sarcomas has always been difficult 
and a touchstone of histological acumen.1,2,3,4 This has been 
exacerbated by confusions in nomenclature, and debate 
concerning what is, and what is not, a sarcoma when 
considering low-grade lesions.5 Another dimension is added to 
the problem when, as happens not infrequently, an undoubted 
sarcoma is poorly-differentiated,6 or shows 
'dedifferentiation•7 (a term used to describe anaplastic 
components resembling MFH in sarcomas of another type such as 
liposarcoma). Yet another considerations are added by the 
importance of grading,8 and staging.9,10 
Treatment modalities can depend very heavily on the 
diagnoses rendered, which are therefore crucial to patient 
welfare. This gives the field a fascination increased by the 
comparative uncommonness with which the entities are 
encountered. This infrequency means that expertise in the 
field is not to be acquired from the occasional sarcomas 
encountered amongst daily routine specimens from general 
surgery. 
In the last decade, the technique of IHC has become 
available. In ideal cases, this enables the pathologist to 
show the direction in which the cells of a tumour are 
attempting to evolve. This can permit a specific diagnosis of 
sarcoma type when morphological differentiation is so 
that the only diagnosis renderable with 
would otherwise be "Sarcoma (NOS)".11 
accuracy and 





technique has somewhat displaced EM without eliminating it -
in the difficult field of sarcoma diagnosis, nothing of 
potential assistance is ignored. 
The diagnostic categories of 
constantly refined, with quantum 
brought about by the advent of 
sarcoma have also been 
leaps in rationalisation 
the newer methods just 
mentioned. The process continues with the discovery and 
expansion of tumour-specific translocations12 such as t(X;lB], 
t(12;160 and t(ll;22) in synovial sarcoma, myxoid liposarcoma 
and malignant peripheral nerve tumours. One of the present 
consequences is that categories of tumour once commonly 
invoked (for example, fibrosarcoma) are now hardly ever 
diagnosed. 
The scope of this study has four aspects, the third and 
fourth of which are intended to give the dissertation 
practical value as a sourcebook and basic guide to the 
diagnosis of sarcomas. 
1. Reassessment of Historical Material. 
Sarcomas diagnosed in the Department of Pathology in the years 
1960-4 are re-examined. This is long enough ago for a definite 
disadvantage to exist 
but recent enough 
in 
for 
terms of techniques then available, 
diagnostic categories (by pure 
3 
morphological criteria) to be essentially recognisable and 
mostly consonant with those in current use. These cases have 
been re-examined by light microscopy ( Chapter 5) . Where a 
discordant diagnosis thereby resulted, the case was submitted 
to IHC (assuming blocked tissue was still available, which was 
not always the case) in an attempt to resolve or refine the 
matter. EM as a diagnostic modality was not used, because it 
would have involved the destruction of irreplaceable tissue 
blocks for doubtful advantage. There has been no attempt to 
secure clinical input to determine the lethal potential of 
tumours; follow-up will have been variable and the issue is 
not whether the original diagnosis was "right" - it is whether 
a contemporary pathologist faced with the same material as his 
historic counterpart would reach the same conclusion. It has 
to be emphasised very clearly that in this intriguing and 
challenging area of tumour diagnosis, many cases are still 
( and perhaps always will be) a matter of opinion. Were it 
otherwise, the field would not hold the interest it does. 
2. Current Incidence. 
An analysis has been made of the records of all tumours 
diagnosed as sarcomas from computerised systematised 
nomenclature records for the years 1986-90, for comparison 
with the earlier five-year period. Then, because the numbers 
were felt to be rather small and perhaps misleading for the 
rarer sarcomas, and 
nomenclature records were 
because microfiched 




(with the exception of 1979), representing a middle period, 
these too were collected as a third, much larger, group. No 
attempt was made to review slides more recent than 1964. The 
most recent material is axiomatically reliable, being made by 
a variety of pathologists from a contemporary perspective and 
with full contemporary advantages, and a review of the middle 
period slides would have been a mammoth undertaking, beyond 
the scope of this dissertation. 
A comparison is made between the incidences of sarcoma 
type as diagnosed in Groote Schuur Hospital in the 5-year 
period 1960-4, before and after revision; in the 5-year period 
1986-90; and in the 11-year period 1971-82 (omitting 1979), 
with comments on the discrepancies ( Chapter 3). Findings are 
compared with those of other series (Chapter 4). 
3. Diagnostic Synopsis. 
An attempt is made to consolidate the morphological criteria 
used in the diagnosis of sarcomas as a series of Venn diagrams 
of the diagnostic categories, showing how cell 
characteristics, architectural patterns and stromal types, can 
combinatively lead to a differential - or at best, unique -
diagnosis (Chapter 6). 
4. Literature Update. 
The sarcoma literature in the major journals has been 
surveyed since the publication in 1988 of the second edition 
of Soft Tissue Tumors,13a and updated references are given for 
each sarcoma type where described in Chapter 5. 
CHAPTER2 
MATERIALS & METHODS 
5 
All cases with the morphological codi~g of 'sarcoma' fell 
into the ambit of the study. Initially, it was felt that this 
should follow the precedent set by, and include all tumours 
covered in Soft Tissue Tumours .13a This would have resulted 
in the retention of some rather disparate entities whose 
status as sarcomas is arguable. Examples are malignant 
paraganglioma, chordoma, and neuro-blastoma and -epi thelioma. 
However, no such cases were retrieved in sufficient numbers to 
justify their inclusion, so that in practice, the tumours (and 
SNOMed morphology codes) covered by this study are: 
Sarcoma Not Otherwise Specified (88003) 
Spindle Sarcoma (88013) 
Epithelioid Sarcoma (88043) 
Malignant Fibrous Histiocytoma (88303) (including 
Fibroxanthoma (88313)) 






Malignant Mesenchymoma (89903) 
Synovial Sarcoma (90403) 
Clear Cell Sarcoma (90443) 
6 
Angiosarcoma (91203) 
Malignant Haemangioendothelioma (91303) 
Kaposi's Sarcoma (91403) 
Malignant Haemangiopericytoma (91503) 
Extraskeletal Osteosarcoma (91803, Extraskeletal) 
Extraskeletal Chondrosarcoma (92203, Extraskeletal) 
Extraskeletal Giant Cell Tumour (92503) 
Ewing's Sarcoma (92603) 
Malignant Peripheral Nerve Sheath Tumour 
(comprising Neurofibrosarcoma (95403) and 
Malignant Schwannoma (95603)) 
Malignant Granular Cell Tumour (95803) 
Alveolar Soft Part Sarcoma (95813) 
(These are classified in order of increasing SNOMed Morphology 
code, and this is the order maintained in subsequent survey 
discussions and tables. Mesotheliomas have been ignored for 
topographical reasons the exclusive definition of 'Soft 
Tissue' used in selecting cases is given below). 
It was sometimes difficult to decide what diagnosis was in 
fact originally rendered. Reports on sarcoma sections tend by 
their very nature to be discursive and contain a list of 
differential diagnoses considered. Of great assistance was the 
SNOMed or SNOP codes actually assigned by the pathologist, and 
in cases of ambiguity of the report, these were generally 
accepted as definitive, except where in conflict with an 
obviously carefully-considered report. Such discrepancy 
sometimes occurred because proper use of the Systematised 
7 
coding had not been made advantage is Nomenclature 
regrettably not invariably taken of codes permitting 
distinction, on an ascending scale of specificity, between 
possible malignancy, 
definite malignancy not necessarily mesenchyrnal, 
Sarcoma NOS (i.e. definite mesenchyrnal malignancy), 
Sarcoma Spindled/Giant cell/Small cell/Epithelioid, and 
Sarcoma (Specific Subtype). 
(However, these were not in any case available for material 
prior to 1971). 
A NEED IS HIGHLIGHTED for reports to give specifically, in 
words, the morphological and topographical assignments 
intended, to counter the possibility of infrequent but 
annoying lack of clarity. Reports on sarcomas, because of 
their complexity, are not infrequently discursive and 
descriptional, and this can lead to unintentional 
discrepancies within the same report, and more frequently to 
discrepancy between different reports on the same tumour 
submitted for examination at different times. Where doubts 
existed as to whether a diagnosis was speculative or favoured, 
the diagnosis allocated for this study was the one which 
seemed to reflect the report most accurately. This requires a 
qualification: in many cases, one diagnosis was favoured above 
others which were not excluded. In such circumstances, the 
favoured diagnosis is 
compilation of cases 
recorded 

















'Soft Tissue' as a topographical site is strictly defined 
as non-visceral. Though some interesting cases are thereby 
lost, tumours of the genitourinary tract are excluded (apart 
from those of the vagina and distally), as are tumours of the 
gastrointestinal tract ( apart from those of the pharynx and 
proximally). Of mesenchyrnal malignancies, those in breast and 
central nervous system ( including eye) were excluded because 
of their peculiarities which qualify them as studies in 
themselves. The thoracic, abdominal and pelvic cavities 
presented interpretational difficulties. Tumours within them 
are generally not included unless clinically noted to involve 
the chest wall or retroperitoneum. However, clinical 
descriptions usually left much to be desired, and here too, 
decisions were made that were of necessity arbitrary at times. 
Metastatic specimens are not included in the statistics, 
although the reference number quoted where more than one 
specimen from the same patient were separately submitted is 
sometimes that of a late or metastatic specimen because the 
material is histologically better or the report more 
definitive. An attempt was made to quote the latest report of 
a particular case falling in the periods surveyed, and ensure 
that it contained a reference to the previous reports, where 
such were known to exist. Patient names were checked to 
exclude multiple entry. It was found that reports generally 
but not invariably gave reference to extant previous 
histology, and in a very small number of cases, it was 
9 
interesting to find a later divergent report made in apparent 
ignorance of an earlier one. 
Cases referred from hospitals outside those served by the 
University Department of Anatomical Pathology are excluded, 
unless the material was referred along with the patient, as 
frequently happens when radiotherapy is undertaken. Such cases 
were identified by the the presence of a request accompanying 
referred tissue/slides that the report be sent to a ward in 
Groote Schuur Hospital. A possible inconsistency in numbers 
may result from the unknown number of "outside" patients 
diagnosed by this Department on referred material as having 
sarcoma in advance of subsequent admission to Groote Schuur 
Hospital for treatment. 
Case records for the period 1960-4 were searched seriatim 
for those meeting the above criteria. For the period 1971-82, 
records were searched via the microfiche for morphology codes 
appropriate to the topographical and other selection criteria 
defined above (1979 being excluded because the relevant 
microfiche is not available). For the period 1986-90, 
computerised records were accessed, cases with the appropriate 
morphology codes printed out and those with inappropriate 
topography excluded. In every surviving case the original 
report was then checked before being admitted to this study. 
Slides for the cases obtained from the 1960-4 records were 
drawn from the archives and reassessed on purely morphological 
grounds. In some cases, re staining or resectioning from the 
block was necessary. Those cases in which it was felt that the 
10 
original diagnosis could be safely amended without further 
investigation (generally 'fibrosarcomas' now classifiable as 
MFH) were taken no further. Those in which IHC or other 
special stains were felt to offer the hope of confirming 
original and/or 
ambiguity were 
current tentative diagnosis or resolving 
submitted to such further investigation. 
an 
In 
this, some cases presented an impasse: blocks were missing or 
cut away, or seemed not to correspond to the description given 
at the time. This highlights another practical recommendation, 
namely that the number of blocks of tissue taken should be 
routinely recorded in all reports for archival purposes, to 
obviate perhaps vital blocks going unknowingly missing. 
The IHC methods used were those standard for the 
commercial antibodies. No modifications are known, or were 
made, to accomodate the age of the material. As there is no 
way to determine time of formalin fixation of the original 
tissue, it is quite possible that a number of IHC failures may 
be due to hyper-fixation. 
CHAPTER3 
SARCOMAS THEN & NOW 
11 
Table 1 shows the distribution of sarcoma diagnosis among 
the diagnostic categories for the three periods under 
consideration, together with the amended distribution for the 
earliest. (Comments on the way in which these amendments were 
made, and the way in which they illustrate the pitfalls and 
dilemmas of diagnosis of sarcomas as a group, are the subject 
of Chapter 5). 
The numerical comparisons are merely to be taken as 
suggestive, since apart from the first group, no attempt has 
been made at standardisation by review of the slides, and the 
diagnoses have been made by many different pathologists, with 
almost certainly differing criteria. Criteria will also have 
altered over the periods considered because of refinements in 
understanding and the description of new entities. Indeed, it 
is the argument of this dissertation that disparity between 
the groups is to be expected, the intention being to draw 
conclusions from them where possible. 
Total numbers of all cases received for histology by the 
Department of Anatomical Pathology of the University of Cape 
Town were 52 351 for the period 1960-4, 160 939 between 1971-
82 (omitting 1979), and 90 672 between 1986-90, and for 
purposes of comparison between each period, the numbers of 
cases given in Table 1 have been normalised () to incidence 
per 100 000 specimens (of all kinds) submitted for histology 
12 
TABLE 1 
DIAGNOSTIC INCIDENCE OF SARCOMA BY TYPE 
(in order of SNOMed listing) 
number of cases and 
(number per 100 000 specimens to nearest integer) 
TYPE 1960-4 1960-4 1971-82 1986-90 
reinterpreted (1979 omitted) 
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* Acronyms - seep v 
E - Extraskeletal 
48 (30) 25 (28) 
4 ( 2) 1 ( 1 ) 
22 (14) 1 ( 1 ) 
28 (17) 29 (32) 
14 ( 9) 11 (12) 
0 0 
53 (33) 7 ( 8 ) 
8 (5) 9 (10) 
27 (17) 12 (13) 
1 ( 1 ) 1 ( 1 ) 
17 (11) 12 (13) 
6 (14) 2 ( 2) 
4 ( 2) 4 (4) 
1 ( 1 ) 0 
29 (18) 20 (22) 
2 (1) 1 ( 1 ) 
0 2 (2) 
1 ( 1 ) 1 ( 1 ) 
3 ( 2) 0 (0) 
0 4 ( 4) 
18 (11) 11 (12) 
0 1 (1) 
3 (2) 0 
289 (180) 154 (169) 
in each. Additionally, 
13 
the data resulting from current 
reinterpretation of the 1960-4 cases is shown in bold figures. 
(All manipulated figures are rounded off to integers). 
I ALL SARCOMAS 
The total incidence of sarcomas in submitted material has 
increased markedly in the last 30 years (the 128 cases per 
100 000 - as reassessed - of thirty years ago growing to 169 
today), but appears to have reached a plateau. Some caution is 
needed in interpreting the figures, 
that the pattern of all histology 
since it could be argued 
submissions has altered: 
sarcomas may not have increased - their dilution by 'other' 
specimens may simply have decreased. A separate study would be 
required to establish this point, but given the modern 
tendency to meticulously submit surgical specimens for, among 
other reasons, litigative security, and the massively 
increased numbers of gynaecological and skin biopsies, 
dilution of sarcomas is more likely to have increased than the 
reverse, and it seems at least possible that sarcoma specimens 
are truly more commonly encountered than they used to be. The 
reason also does not appear to be that they were 
underdiagnosed thirty years ago, since a reappraisal of the 
material resulted in 11 of 78 specimens (14 %) being 
reallocated a diagnosis other than soft tissue sarcoma. The 
converse parameter - the number of sarcoma diagnoses missed -
is unknown. 
If the proportion of sarcoma specimens 
14 
has truly 
increased, is this because sarcomas now occur more frequently 
than they did? It seems inherently unlikely, al though within 
the group, it is difficult to account for the tremendous 
incidence of liposarcoma specimens in the middle period of the 
three surveyed purely by changes in investigational and 
management procedures. It seems likely, though, that two 
factors may have resulted in the apparent increase of sarcomas 
as a whole. One is that more tumours are submitted because of 
the availability of needle biopsy (paradoxically, of very 
limited value in this area of oncology). The other is the rise 
of radiotherapy and the expert in soft tissue pathology, both 
of which have resulted in cases being increasingly referred to 
this hospital. 
Table 2, using the data of Table 1, shows, for each 
period, the approximate percentage (relative to all sarcomas 
diagnosed in the period) of each morphological category (the 
figures have been rounded to the nearest integer so that the 
sums are not exactly 100). Table 3 groups the findings into 
three: common, uncommon and rare sarcomas. 
The distribution of diagnoses for all periods combined is 
shown histogrammatically in Fig. 1. Fig. 2 shows just the most 
recent series ( 1986-90) for comparative purposes, listed in 
the same order as in Fig. 1. Figs 3 and 4 show the effect of 
reinterpretation on the two largest original subgroups of 
sarcoma: sarcoma NOS and fibrosarcoma, respectively. 
TABLE 2 






































































* Acronyms - seep v 




























Figures are rounded to the nearest integer 
TABLE 3 
QUALITATIVE RANKING OF DIAGNOSTIC FREQUENCY 
WITHIN SARCOMAS 
(The findings are the same for each of the 3 periods except 
where otherwise specified). 
COMMON (generally >10%) 
Sarcoma Nosl (uncommon 1961-4 reinterpreted), MFH2*, 
Kaposi 1 s 3 (rare 1961-4 before/after reinterpretation) 
UNCOMMON (generally 5 - 10%) 
DFP* (common 1961-4 reinterpreted), 
Lipo- (common, 1971-82), Leiomyo- (rare, 1971-82), 
Rhabdomyo-, ss* (rare, 1961-4 before reinterpretation), 
MPNST* 
RARE (qenerally <5%) 
Epithelioid, Fibro- 4 (common, 1961-4 before 
reinterpretation), Myxo-, MM*, ccs*, Angio-, MHE*, 
16 
MHP*, Osteo-E, Chondro-E, EGCT*, Ewing's, MGranCT*, ASPS 
* Acronyms - seep v 
1 - marked decrease overall 
2 - less frequently diagnosed in the 1971-82 period 
3 - marked steady increase in diagnosis and now common. 
4 - marked decrease in diagnosis and now rare. 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































II SARCOMAS BY TYPE 
The most striking finding, considering the data in Table 
2, has been the decrease in the diagnosis of Sarcoma NOS and 
Fibrosarcoma over the years. Sarcoma NOS has shrunk, it is 
generally argued, because of the advent of IHC and US 
sarcomas (41%) were not techniques. In 1960-4, 
further diagnosable; by 
32 of 78 
applying IHC 
categories, this was reduced to 3 of 
and modern diagnostic 
67 (4%) (and in 2 of 
these, a diagnosis might still have been possible if blocks 
had been available for IHC); 10 of the originals were felt not 
to be sarcomas, and one not to be a soft tissue sarcoma. Yet 
the rationalisation is less due to modern techniques than to a 
clearer understanding of sarcomas and an expansion of the 
diagnostic categories largely by morphological criterial This 
argument is supported by the fact that as few sarcomas were 
diagnosed as 'not otherwise specifiable' in the middle period 
cases of 1971-82, before IHC became available as they were 
after. In fact, it is rather striking that the figures for 
this period ( 48 of 289 diagnoses, 17%) is no different from 
those of the late period cases of 1986-90 (25 of 154 cases, 
16%) I 
The single most important category 
sarcoma diagnosis has been that of MFH.14 
in rationalising 
Many of the cases 
previously diagnosed as 'sarcoma NOS' or 'fibrosarcoma' fell 
into the new category, and it was principally for this reason, 
rather than the advent of IHC, that unspecifiable sarcoma and 
fibrosarcoma diminished in diagnostic frequency. In fact, the 
20 
diagnosis of MFH is in danger of becoming a net, as 
f ibrosarcoma and unspecif iable sarcoma used to be. Attention 
has been drawn by Dehnerl5 to the 'nosologic haven' provided 
by MFH for difficult-to-classify, pleomorphic sarcomas. The 
pattern of MFH may be arranged like MPNST, sclerosing 
liposarcoma, fibrosarcoma and haemangiopericytoma, or 
disarranged like pleomorphic lipo- or rhabdomyo-sarcoma or 
leiomyosarcoma (see Chapter 5). It accounts for a fifth of all 
cases, in the early (revised) and late groups, but for only a 
tenth in the middle group, perhaps because of the contribution 
made by liposarcomas. 
From Tables 2 & 3, it will be seen that there is 
substantial concurrence between periods on most entities Those 
for which agreement is lacking are: 
Sarcoma NOS and fibrosarcoma, for reasons already 
explained. 
DFP over-represented in the reinterpreted earliest 
group, 
Liposarcoma, over-represented in the 1971-82 group 
Leiomyosarcoma under-represented in the 1971-82 
group. 
Kaposi's sarcoma, showing an increase with time. 
The frequency variations in MHP and leiomyosarcoma may be more 
apparent than real (especially in the case of the former) 
since the numbers are small, and it is not proposed to discuss 
the matter further. 
21 
1. Liposarcoma vs other myxoid sarcomas. 
One speculates that perhaps a number of pleomorphic 
liposarcomas in the middle group could be recategorised as 
myxoid MFH, thereby adjusting the balance between both groups 
to something more like that seen in 1986-90. Myxoid 
rhabdomyosarcoma and MPNST might also, on reinvestigation, 
prove to increase at the expense of liposarcoma. In view of 
the fact that the diagnosis of liposarcoma was almost 
invariably made with confidence, it is unlikely that 
lipomas/myxomas accounted for many cases. If a 'lacy' pattern 
is present, sarcomas other than liposarcoma are unlikely 
(Chapter 5), the only ones warranting consideration being 
epithelioid leiomyosarcoma, clear cell sarcoma and myxoid 
(botryoid) rhabdomyosarcoma, which are rare. The only 
liposarcoma with an 'arranged' pattern is the sclerosing 
liposarcoma, which is the least common liposarcoma, so that 
the wide number of differential diagnoses it raises can be 
ignored as a source of potential significant misattribution in 
our data. Liposarcoma with a 'disarranged' pattern is 
essentially pleomorphic liposarcoma, and this can mimic MFH 
and rhabdomyosarcoma, as already mentioned, but in the middle 
period, only one liposarcoma in 7 was reported as pleomorphic, 
the remaining 6 being almost equally divided between myxoid 
and well-differentiated. One is left with the conclusion that 
the middle period liposarcomas warrant reappraisal. 
22 
2. Leiomyosarcoma vs MFH, monophasic SS, MPNT, embryonal 
rhabdo-myosarcoma. 
Considering the relatively underdiagnosed leiomysarcomas 
of the middle period, a number of differentials exist for the 
'sweeping' pattern (see Chapter 6). The 'sweeping' pattern 
classically characterises leiomyosarcomata, although they can 
on rare occasion have an 'arranged' pattern when palisades are 
present, or less uncommonly, a 'disarranged' pattern when 
architecturally more anarchic (Chapter 6). 
First, 
pattern, 
discussing only differentials for the 'sweeping' 
fibrosarcoma and haemangiopericytoma can be 
discounted as potential sources of 'extra' leiomyosarcomas 
because of their rarity, leaving monophasic ss, MPNST and 
rhabdomyosarcoma. None of these were apparently relatively 
over-diagnosed during the period, so are, purely on numerical 
grounds, an unlikely source of additional cases. However, they 
can present diagnostic pitfalls, making distinction dependent 
on minor features. Thus, whilst 
vascular stroma may be a feature 
alike, inflammatory cells are 
giant cells, necrosis and 
of MFH and leiomyosarcoma 
not usually found in 
leiomyosarcoma, and hyaline stroma is not 
MFH; whilst monophasic epithelioid SS and 
leiomyosarcoma, have myxoid, vascular or 
inflammatory cells may be present in SS, 
usually found in 
MPNST may, like 
hyaline stroma, 
and the cells of 
MPNST are characteristically wavy; whilst myxoid and vascular 
stroma may be a feature of both leiomyosarcoma and 
rhabdomyosarcoma, hyaline stroma is not found in the latter. 
23 
Turning to the 'disarranged' leiomyosarcoma, this has 
already been mentioned (in consideration of the possible 
overdiagnosis of liposarcoma) as a differential of the 
pleomorphic liposarcoma, of which there were 6 diagnosed in 
the middle period. Although both leiomyo- and pleomorphic 
lipo-sarcoma may exhibit a myxoid or a fibrillary stroma, the 
hyaline stroma, if found, should permit a distinction in 
favour of leiomyosarcoma. 
In the reassessment of 1960-4 cases, 2 out of 32 cases 
described as 'Sarcoma NOS' were reallocated to leiomyosarcoma, 
so that the category of unspecified sarcomas would not seem a 
good source of leiomyosarcomas. Yet this is the likeliest 
explanation for the under-representation of leiomyosarcomas in 
the middle period. Of the 289 1971-82 sarcomas, 48 were 
diagnosed as 'Sarcoma NOS', representing 17%, and 8 were 
diagnosed as 'leiomyosarcoma' representing 3%. If a mere 10% 
of sarcoma NOS' proved on reassessment to be 
leiomyosarcomata, which is quite possible, then the 
percentages of sarcoma NOS' and leiomyosarcoma diagoses for 
the period would become 14 and 6% respectively, which would 
not differ greatly from the 1986-90 figures. This would 
illustrate the diagnostic difficulty provided by plump 
spindle-celled malignancies when IHC and EM are unavailable to 
take the diagnosis further, resulting in the safest diagnosis 
being one of uncategorised sarcoma. 
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3. Kaposi's Sarcoma 
The recent increase in clinical cases is attributed to the 
association with HIV infectionl6 and iatrogenic 
irnrnunosuppression, al though AIDS- and transplantation-related 
Kaposi's sarcoma are only two of four forms of the disease. 
The others are chronic, and lyrnphadenopathic13b (which roughly 
correspond to the epidemiological types sporadic and 
endemic. 17 However, the statistics of Table 2 show that the 
rise in histological cases antedated the AIDS epidemic which 
began after the middle period surveyed. 
Although there is growing familiarity with the entity, the 
diagnostic criteria have not changed. Two of the three 
diagnoses made on the earliest material were confirmed on 
review (the third was 
haemangioendothelioma), and 
the other sarcomas. However, 
thought to be a malignant 
no additional cases found among 
it is not possible to say how 
many Kaposi's sarcomas might have been misdiagnosed as benign 
neoplasms such as haemangioma, or as non-neoplastic lesions 
such as pyogenic granuloma and fasciitis, which enter the 
differential. 
Kaposi's sarcoma is characterised by a 'sweeping' pattern 
without the hyaline stroma (Chapter 6) which can help 
distinguish leiomyosarcoma, MPNST and monophasic synovial 
sarcoma. Because of its vascularity, it needs to be 
differentiated from angiosarcoma, haemangioendothelioma and 
haemangiopericytoma, which are rarer. The cells of Kaposi's 
sarcoma (thought to be of vascular endothelial origin)18 lack 
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the epithelioid appearance of these, though the distinction 
can be difficult. Embryonal rhabdomyosarcoma and biphasic 
synovial sarcoma are commoner and also may be vascular, but 
the distinction is not generally a problem. 
If the local increase in Kaposi's sarcoma in the 1970s is 
real, could HIV have been responsible long before it was 
identified in the Northern Hemisphere? If that were the case, 
why was the prevalence of HIV seropositivity so low when 
testing for it began in South Africa in the mid-1980s? The 
dramatic increase in seropositivity has only been recent. May 
the 1970s increase rather be suggestive of an aetiological 
factor additional to those currently recognised? It is 
interesting to note that an increase in Kaposi's sarcoma 
similar to the one suggested by the data of Table 2 has been 
documented in Sweden, occurring in the elderly at the end of 
the 1960s, when Kaposi's sarcoma doubled. This has been 
adduced as possible evidence for the role of a hitherto-
undetected retrovirus.19 The aetiology of Kaposi's sarcoma is 
not clearly defined; a number of viruses including HIV and 
CMV, and even a dual viral infection with CMV and an 
unidentifiable second virus99 have been considered. More 
probably, these are only secondary causes, provoking the 
primary one of an imbalance between the immune system and 
endothelial cells, which seem interdependent in angiogenesis. 
Oncogenes have also been implicated. It seems therefore likely 
that Kaposi's sarcoma is an end-result of a variety of 
unequally-important initiating processes.17 
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CHAPTER4 
COMPARISON WITH OTHER PUBLISHED SERIES 
The distribution of sarcomas with respect to morphological 
type has been examined in three series published after the 
beginning of the work described in this Dissertation. Fisherll 
examined 200 sarcomas to show the value of EM and IHC in their 
diagnosis. A Scandinavian group20 reviewed 240 sarcomas 
selected as 'high grade', and listed original and revised 
diagnoses, using IHC in an unspecified number. In neither case 
was the interpretation of 'soft tissue' defined. Patients 
under the age of 15 were specifically excluded from the 
Scandinavian study. The Eastern Cooperative Oncology Group of 
America21 reviewed sarcomas of adult bone and soft tissue 
totalling 358 (after exclusion of 66 mesotheliomas), using IHC 
and EM in unspecified numbers. In this series, 'soft tissue' 
specifically included gastrointestinal tract, and uterus. 
The form in which the data is presented reveals the 
details of specific alterations made on review in the 
Scandinavian paper. The American gives only the numerical 
alteration made on review to each sarcoma category. Fisher's 
diagnoses are all primary. 
Table 4 shows final diagnoses as a rounded percentage of 


























SARCOMA TYPES AS% OF TOTAL 
(in order of SNOMed listing) 
as % of total in four independent series) 
Cape Town America 21 Scandinavia20 Englanctll 
510A 67B 257C 226D 200 
15 4 3 5 4 
1 1 <1 <1 4 
5 4 5 2 2 
14 21 16 42 28 
7 12 
12 4 8 9 19 
5 9 38 9 4 
8 6 <l <1 13 
<1 0 <1 2 
7 7 5 15 10 
2 1 <1 1 
2 0 1 1 2 
<1 3 
10 3 <1 
1 3 4 2 <1 
<l 0 >4 1 2 
<1 0 >5 2 2 
<1 1 
1 3 3 <1 3 
7 10 5 6 6 
<1 0 <1 
1 4 2 2 
* Acronyms - seep v 
A - early (reinterpreted) plus middle plus late series 
combined, as discussed in Chapter 2 and shown in Fig. 1 
B - early (reinterpreted) cases only, as shown in Table 2 
C - Adult cases only, not restricted to soft tissue. Includes 
gastrointestinal tract, uterus and bone. 
D - Adult cases only. 
E - Extraskeletal (except in American series). 




our series of 67 reinterpreted cases 1960-4 as listed 
in Table 1. 
our grand combined series (also shown in Fig. 1) of 
510 cases (of which the 67 cases just referred to form a part. 
The other 443 cases have not been reinterpreted; 289 are from 
1971-82 [1979 omitted] and 154 from 1986-90, as listed in 
Table 1). 
the American series of 257 final reinterpreted 
diagnoses. 
the Scandinavian series of 226 final reinterpreted 
diagnoses. 
Fisher's series of 200 diagnoses. 
Inter-series comparison must take into account that the 
selection criteria are not the same in each, and the fact that 
our own review is the only one to feature historical material 
for which some current diagnostic categories were originally 
nonexistent, so that the diagnostic turbulence it refelects 
will automatically be more severe. 
Table 5 shows the proportion of original diagnoses in each 
sarcoma category which were revised on reappraisal. This .1s 
also expressed as a percentage where 5 or more cases were 
reviewed. The figures given for our study are those of the 78 
re-examined cases of 1960-4 (see Table 7) 
Table 6, using the data of Table 5, groups sarcomas into 
categories according to the instability of diagnosis as 
expressed by likelihood of revision on review. There appeared 
to be four natural categories as follows: 
TABLE 5 
SARCOMA DIAGNOSES REVISED ON REVIEW 
(in order of SNOMed listing) 























in three independent series 
Cape Town Arnerica21 Scandinavia20 
55/78 (70) 8 101/358c (28) 
30/32 (94) 22/30 (73) 
10/11 (91) 14/27 (52) 
10/51 (20) 
0/4 
2/5 (40) 6/26 (23) 
1/4 15/112 (13) 
2/4 10/12 (84) 
1/1 F 




0/2 2/11 (18) 
5/14 (36) 
0/14 ( 0) 
<1 F 
0/7 ( 0) 
5/6 (82) 3/16 (19) 
F 
0/2 0/4 
* Acronyms - seep v 
A - shown only where five or more cases reviewed 

















C - Adult cases only, not restricted to soft tissue. Includes 
gastrointestinal tract, uterus and bone. 
D - Adult cases only, restricted to soft tissue. 
E - Extraskeletal (except in American series). 















INSTABILITY OF SARCOMA PRIMARY DIAGNOSIS TO AMENDMENT 
in three independent series 
America 21 Scandinavia20 
Sarcoma NOS vu vu 
Cape Town 
vu 






































vs (Very stable) 
U (Unstable) 
S ( stable) 
VU (Very Unstable) 
(as defined on p 31) 
Bold type indicates results which are discordant in one series 
(in which 5 or more examples were reviewed) when compared with 
the two others. 
Lower case type indicates series which contain fewer than five 
examples reviewed, and for which categorisation is therefore 
hardly justified. 
* Acronyms - seep v 
E - Extraskeletal (except in American series). 
30 
31 
Very Unstable (VU): >63% revised 
Unstable (U): 38-63% revised 
Stable (S): 13-37% revised 
Very Stable (VS): <13% revised 
The American series was used in setting the cutoff points, as 
it contained the largest number of cases. ( Lower case type 
shows a tenuous conclusion based on less than 5 cases. Bold 
type indicates results where one series appears to differ 
rather strikingly from those in the other two). 
Comparing the incidence of various sarcoma types in the 5 
series shown in Table 4, there is substantial agreement. The 
excess of leiomyosarcomas and bone tumours in the American 
series is explained, as already noted, by topographically 
unrestricted selection criteria. 
MFH and SS are relatively over-represented in the 
Scandinavian series, and MFH, liposarcoma and rhabdomyosarcoma 
in the English. 
Our own main series shows an excess of sarcoma NOS, but 
only in that part of it which has not been totally 
rescrutinised with benefit of IHC; the subseries for which 
this has been done is in line with others' 
and sub-series, like the English one, 
findings. Our main 
contains a higher 
percentage 
included. 
of rhabdomyosarcoma because 
Ours also show a striking 
paediatric 
incidence 
sarcoma, as already discussed in Chapter 3. 
Although our main series has approximately 






others, these percentages in the subseries are somewhat higher 
in the case of MPNST (10%) and significantly lower in the case 
of liposarcoma (4%). We argued, in Chapter 3, that the 
relative abundance of liposarcomas, amounting to 18% of the 
1971-82 tumours (Table 2), might be the result of misdiagnosis 
of other myxoid sarcomas, yet this figure is even exceeded by 
the English one (Table 4), which at 19% is twice as large as 
found by the Scandinavian and American authors. 
One attributes the excess of MHE and ASPS our subseries to 
fluctuations in small numbers which do not warrant further 
discussion. 
In the Scandinavian series, the most common missed 
diagnosis was MFH in cases reported as: sarcoma NOS, 
liposarcoma, leiomyosarcoma, rhabdomyosarcoma and MPNST. In 
cases reported as MFH, the most common missed diagnosis was 
one of benign tumour. (However, the extraordinary proportion 
of MFH in this series see Table 4 suggests possible 
overdiagnosis).15 In our review of 1960-4 cases, we too found 
MFH to feature in the revisions of sarcoma NOS (8 out of 32), 
leiomyosarcoma ( 1 out of 4), rhabdomyosarcoma ( 1 out of 4), 
and MPNST (1 out of 6), and also found it in fibrosarcoma as 
construed in that era (3 out of ll)(Table 7). 
CHAPTER5 
A RE-EXAMINATION OF 78 SARCOMAS 
REPORTED IN 1960-4 
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It is said22 that 4-10% of neoplasms routinely examined 
present diagnostic difficulties, many of which are not 
intrinsic, being related to poor sampling, preservation, or 
lack of clinical data. Of the intrinsic difficulties, there 
are morphology and pattern-type problems, and discordant IHC. 
Immunohistochemistry is only secondarily a matter of 
interest in this dissertation, although the 
immunohistochemistry of intermediate filaments22 has made 
great strides possible in the diagnosis of sarcomas,23 to the 
point where choice of antibodies requires careful 
reflection.24 The use of CD (cluster of differentiation) 
Antigens rather than intermediate filaments as tissue markers 
in the field of sarcomas is still in its infancy, but a start 
is being made here too.25 
The diagnostic problems resulting from IHC conflicts are 
currently in great vogue, as the method enters its mature 
phase. Numerous publications have been spawned, and 
retrospective analyses been conducted. For example, the many 
reports of cytokeratin-positivity in sarcomas drew the comment 
that "those ... who have not encountered widespread cytokeratin 
reactivity in mesenchymal neoplasms, and those ... who are 
struggling to interpret the significance of others' 
experiences, are left to view this debate much as Alice 
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pondered the Cheshire cat: a smile with seemingly little 
substance. But let us be wary that the cat is not laughing at 
us" . The comment achieves the distinction of being as 
enigmatic as its metaphor.26 
Of greater interest is the morphological aspect of 
diagnostic disagreement. Comparisons between current 
(reassessed) diagnosis and original diagnosis for the 78 
1960-4 sarcomas in the study are presented in Tables 7 and 8. 
Table 7 shows the sources of the current diagnoses, and 
Table 8 the changes made to the original diagnoses, which are 
also shown diagramatically for the relatively large subgroups 
of original diagnoses of Sarcoma NOS in Fig. 3 and of 
Fibrosarcoma in Fig. 4. It must be remembered that none of the 
qualifications have been entered in these Tables that would 
have accompanied the report of each case, and not all 
diagnoses have equal weight: diagnoses for which there 
exist(ed) serious reservations were entered as sarcoma NOS', 
but even within specific categories, some cases were diagnosed 
as certain, others as probable examples. 
The features used in an attempt to characterise each 
diagnostic category of sarcoma are summarised below, at the 
beginning of the relevant subsections. The criteria are 
presented collectively in Chapter 6 and Figs 5. Where 
illustrative, reference is made to what are considered to be 
previously miscategorised lesions. 
TABLE 7 
PREVIOUS vs CURRENT DIAGNOSES 
COMPARED FOR 78 1960-4 SARCOMAS 
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Previous Diagnosis No 
Sarcoma NOS 32 
currently Diagnosed As 
Sarcoma NOS (2), MFH* (8), MPNST (4), 
Leiomyo-(3), Rhabdomyo- (2), 
Ewing'sE (1), EGCT* (1), 
Epithelioid sarcoma (1), ccs* (1), 
Fibro-(1), SS (1), ASPS (1), 
Spindle carcinoma (3), 
Neurilemmoma (1), 
Proliferative myositis (1) 
Nodular fasciitis (1) 
See Fig. 3 
Fibro- 11 Fibro-(1), MFH (3), DFP (3), 

























see Fig. 4 
DFP (4) 
Myxoma (1), Nodular fasciitis (1) 
Lipo-(3), Myxoma (1), ss (1) 
Leiomyo-(3), MFH (1) 
Rhabdomyo-(2), MFH (1) 
Epithelioid haemangioendothelioma (1) 
Myositis ossificans (1) 
SS (1), Ewing'sE (1) 
Kaposi's (2), MHE* (1) 
MHP (2) 
MPNST (1), Fibre- (1), 
MFH (1), DFP (1), SS (1), 
Clear cell sarcoma of kidney (1) 
ASPS (2) 
* Acronyms - seep v 
E - Extraskeletal 
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TABLE 8 
CURRENT vs PREVIOUS DIAGNOSES 
COMPARED FOR 78 1960-4 SARCOMAS 
current Diagnosis 























































Previously Diagnosed As 
Sarcoma NOS (2), Fibro- (1). 
Sarcoma NOS (1). 
Fibro- (1), MPNST (1), Spindle (1) 
Sarcoma NOS (8), Fibro- (3) 
Leiomyo- (1), MPNST (1), 
Rhabdomyo- (1). 
DFP (4), Fibro- (3), MPNST (1). 
Lipo- ( 3). 
Leiomyo- (3), Sarcoma NOS (3). 
Rhabdomyo- (2), Sarcoma NOS (2). 
SS (1), Sarcoma NOS (1) MPNST (1), 
Fibro- (1), Lipo- (1). 
Sarcoma NOS (1). 
Rhabdomyo- (1), Kaposi's (1). 
Kaposi's (2). 
MHP ( 2). 
Sarcoma NOS (1). 
Sarcoma NOS (1), ss (1). 
MPNST (1), Sarcoma NOS (4), 
Fibro-(2) 
ASPS (2), Sarcoma NOS (1). 
MPNST (1). 
sarcoma NOS (2), 
spindle Sarcoma (1). 




Lipe- (1), Myxosarcoma (1). 
* Acronyms - seep v 


























































































































































































































































































































































































































I SOFT TISSUE SARCOMAS 
1. Sarcoma NOS (3 cases) 
This is a default diagnosis, and the fact that only 3 were 
made in the period supports Fisher's figurell of only 3.5% of 
sarcomas remaining unclassifiable after recourse to IHC and EM 
where necessary. It possibly also reflects a greater readiness 
to make a committed diagnosis when clinical action is not to 
be undertaken; the extent of this is difficult to assess, but 
it undoubtedly induces a subconscious freedom. 
All three cases show the problem of diagnosis of a 
spindle-cell lesion without qualifying features. All showed a 
sweeping pattern for which the differential is wide. Two cases 
had been diagnosed as sarcoma NOS originally. In both, the 
cells were spindled, some being rather epithelioid, without 
giant cells. One [7025/63) was 
vascular, with an impression 
in addition nucleolated, 
of 'staghorn' vessles. 
and 
The 
diagnoses considered for this were carcinoma, melanoma and, 
giving weight to the vessels, malignant haemangiopericytoma, 
but only enough tissue remained in the block to show vimentin 
positivity and cytokeratin negativity. The other case 
[6293/62] was rather myxoid and had a suggestion of whorling, 
so that a diagnosis of MPNST was favoured, but no block was 
available. 
The third case [7749/61], related to the mandible, 
originally diagnosed as a low-grade fibrosarcoma, was likewise 
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vascular, but with fibrillar stroma, plump spindle cells and 
slightly myxoid areas. A monophasic fibrous synovial sarcoma 
was favoured on reassessment, but the specimen was poorly 
preserved (possibly because of decalcification procedures) and 
IHC uniformly negative. 
The conclusion is that in poorly differentiated tumours, 
an analysis of patterns and stroma can be insufficient in the 
absence of the subtle features which confirm a diagnostic 
suspicion. It can also sometimes be questionable whether a 
low-grade tumour is malignant at all; epithelioid and 
nucleolated tumours, especially, raise doubts about 
mesenchymal origin which are best put to the test with 
vimentin. 27 The converse is not true: epithelial markers are 
positive in carcinosarcoma (sarcomatoid carcinoma). 
2. Epithelioid sarcoma (Figs 5, 5.4) (1 case) 
Pattern: epithelioid 
Stroma: fibrillar 
Cells: granular epithelioid 
Additional features: +/- necrosis, inflammatory cells, 




spindled areas, sclerosis, nodularity. 
criteria, including necrosis, inflammatory cells, 
and nodularity are met by the single example 
originally thought to be vascular. The stroma was 
felt to be more fibrillar than vascular on reassessment, and a 
stain for Factor 8 marked entrapped capillaries rather than 
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tumour. (Cytokeratins and neurofilaments have been reported in 
epithelioid sarcoma). 28 A more recent differential diagnosis 
to be considered for any epithelioid sarcoma would be 
malignant rhabdoid tumour of soft tissue.29 
Epithelioid sarcoma has been reported to develop diffuse 
bone marrow metastases and an associated leukemoid reaction.30 
3. Fibrosarcoma (Figs 5, 5.2, 5.3, 6) (3 cases) 
Pattern: arranged (herringbone)/sweeping 
Strama: hyaline 
Cells: plump spindle 
Additional features: inflammatory cells (infantile form), 
+/-necrosis, sclerosis 
The criteria were well met by one of the three cases, 
originally diagnosed as a spindle cell sarcoma [1656/64]. 
Another (3022/61] had been diagnosed as malignant and probably 
of neurogenic origin. It was true that the pattern was 
arranged, being slightly whorled, but it was more strikingly 
fascicular, with definite 'herringbone' areas. The cells were 
plump spindle, and the stroma hyaline without showing myxoid 
or vascular properties. IHC for S100 was, as expected, 
negative, and the lesion classified as a probable 
fibrosarcoma. 
The third case (7560/63], occurring in relation to the 
mandible of a child, illustrated the sometimes decisive value 
of a clinical history. The pattern was sweeping, with a loose, 
though not myxoid, fibrillar appearance and hyaline fascicles 
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coursing through it. It also contained numerous inflammatory 
cells, compatible with possible infantile fibrosarcoma. This 
diagnosis was preferred to an odontogenic neoplasm because of 
the age of the patient. 
The reluctance to diagnose fibrosarcoma perhaps represents 
too far a swing of the pendulum away from this once common 
entity (see Fig. 4) as a result of a discouraging awareness of 
MFH and monophasic synovial sarcoma.31 
4. Malignant fibrous histiocytoma (Figs 5, 5.1-3, 6) 
(14 cases) 
Pattern: arranged (storiform)32;disarranged/sweeping 
Stroma: myxoid/hyaline/fibrillar/vascular 
Cells: plump/slender spindle. Epithelioid in pleomorphic MFH 
Additional features: multinucleate giant cells, 
inflammatory cells, +/- necrosis 
Seven of the 14 cases were typical, and met the major 
criteria of storiform pattern with giant cells. Three 
had previously been called fibrosarcomas, [8576/60, 
9054/61,1722/63] and 
5490/61,5679/62,7654/64]. 
4 sarcomas NOS 
Difficulties with the 
[4724/60, 
diagnosis 
arise in the absence of areas with an arranged pattern. 
Cases with disarranged 
storiform): 
pattern (i.e. not 
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conclusively 
Three of the sarcomas NOS [3589/61,3784/61,6043/62] showed 
a predominantly disarranged pattern (though with giant and 
inflammatory cells present in accord with MFH). The 
possibility of spindle-cell carcinoma and melanoma was raised 
because of their epithelioid cells and nucleolation. It was 
excluded by IHC (vimentin positivity, S100 and cytokeratin 
negativity) . 
Another sarcoma NOS [ 3750/64), and a tumour tentatively 
diagnosed previously as a rhabdomyosarcoma [ 6213/61), showed 
disarranged patterns, and giant cells, but no inflammatory 
cells. They had fibrillary stroma and very plump and rather 
epithelioid cells, highly suggestive of pleomorphic 
rhabdomyosarcoma. However, PTAH staining revealed no cross-
striations, desmin IHC was negative (except in the second case 
where the cells marking were entrapped muscle), and IHC with a 
histiocytic marker (Mac387) focally positive. 
A case previously called leiomyosarcoma [5581/64], with a 
disarranged pattern and giant cells, showed hyaline stroma 
supporting the diagnosis. Inflammatory cells were sparsely 
present, however, and the cells rather epithelioid for the 
diagnosis. Some of the spindle cells were also rather slender. 
The preferred diagnosis of MFH was supported by negative 
desmin IHC and positivity with Mac387. 
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Case with sweeping/?arranged (whorled) pattern, doubtfully 
storiform: 
Another case (1878/63], previously called neurogenic 
sarcoma, had, in agreement with this diagnosis, a suggestion 
of whorling, and densely-packed epithelioid and plump spindle 
cells, myxoid and hyaline areas alternating. Inflammatory and 
giant cells were not present. However, SlOO was negative and a 
histiocytic marker (Mac387) positive. 
The cell of origin of the MFH continues to provoke 
controversy, and that it is histiocytic is strongly 
disputed.33 It is usually vimentin-positive, but has been 
reported in some instances to express cytokeratin, 34, 35, 36, 37 
neurof ilament35, 35, 3 7 and even desmin. 35, 3 6 The angiomatoid 
variant has recently been reviewed, 38 and evidence from IHC 
led to support myoid differentiation for it on one hand39 and 
histiocytic origin on the other. 40 A warning has been made 
concerning the differentiation from an atypical 
pseudosarcomatous variant of cutaneous benign fibrous 
histiocytoma, 41 and a case reported of mul ticentric MFH. 42 
There appears to be a correlation between the histologic 
grading of MFH and the extent of its Ki-67 staining.43 The 
relationship of subtype of MFH to prognosis has been 
investigated in a large recent series.44 
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5. Dermatofibrosarcoma protuberans (Fig. 5, 5.2, 6) (8 cases) 
Pattern: arranged (storiform) 
Stroma: hyaline/vascular/myxoid/fibrillar 
Cells: slender spindle 
Additional features: nodular. Giant/inflammatory cells sparse. 
Of the 8 cases, 6 were typical and met the criteria of a 
storiform pattern with low-grade features. Of these, 2 had 
originally been diagnosed as DFP [2193/61,10007/62], 3 as 
fibrosarcomas [7734/60,2775/61,2343/63], and 1 as a low grade 
sarcoma of possible neurogenic origin [89/61]. 
The other 2 cases, because of pattern, were not quite as 
straightforward, although diagnosed originally as DFP. One 
[ 2473/61), having an arguably storiform pattern with hyaline 
stroma and without giant or inflammatory cells, was quite 
cellular and areas of it sweeping rather than arranged. This 
raised the possibility of a fibrosarcoma or leiomyosarcoma. 
(DFP with fibrosarcomatous areas is a recently-described 
entity,45 but in favour of the diagnosis of DFP, the spindled 
cells were slender rather than plump, and desmin was negative. 
The other case [ 712/61] had a whorled rather than storiform 
pattern that suggested neural origin, but S100 was negative. 
The histogenesis of DFP has recently been investigated.46 
A granular cell variant has been described.47 The relationship 
to the uncommon low-grade childhood lesion of Giant Cell 
Fibroblastoma (GCF) has been the subject of considerable 
discussion,48 and GCF has been shown to recur as DFP49 and to 
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co-occur with DFP.50 The patterns of extension into tissue of 
deep dermatofibromas have been compared with those of DFP to 
distinguish the two in the occasional cases encountered of 
deep dermatofibroma.51 
6. Liposarcoma (Figs 5, 5.1, 5.2, 5.4, 5.5, 6) (3 cases). 
Pattern: lacy (well-differentiated, myxoid, round cell, 
sclerosing) 
disarranged (pleomorphic) 
epithelioid (round cell,) 
arranged (sclerosing) 
Stroma: myxoid/vascular (well-differentiated, myxoid, round 
cell, sclerosing, pleomorphic) 
hyaline (sclerosing) 
fibrillar (pleomorphic) 
Cells: spindled (well-differentiated, myxoid, 
sclerosing, pleomorphic) 
granular epithelioid (round cell, pleomorphic) 
clear epithelioid (pleomorphic, epithelioid) 
lipoblasts must be present 
Additional features: giant cells in pleomorphic liposarcoma 
prominent vascularity in all forms. 
All 3 cases were typical and met the criteria, 2 being 
myxoid [3470/62,5997/62] and one well differentiated 
[5694/61]. Previous diagnoses of all were in agreement. 
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Liposarcomas have not been the subject of as intensive 
publication recently as have some other sarcomas, but one 
study of 111 cases of various types showed that myxoid 
liposarcoma has the best prognosis and pleomorphic the worst, 
with well-differentiated being intermediate. The need was 
expressed for a category of 'atypical lipoma' for diverse non-
retroperitoneal lesions of adipose tissue with good 
prognoses.52 In another study of 127 cases, however, well-
differentiated liposarcoma had best prognosis, followed by 
myxoid, and pleomorphic. Fibroblastic and lipoblastic variants 
were recognised in this study, fibroblastic carrying a 
prognosis akin to that of pleomorphic, and lipoblastic having 
the worst prognosis of all. 53 (Round cell liposarcomas were 
not included as such in either study). 
7. Leiomyosarcoma (Figs 5, 5.1-5, 6) (6 cases) 
Pattern: sweeping/disarranged/rarely arranged (palisaded) 
epithelioid/lacy (epithelioid variant) 
Stroma: hyaline/fibrillar/vascular/myxoid 
Cells: plump spindle 
epithelioid (epithelioid variant) 
Additional features:+/- giant cells, necrosis 
Of the 6 cases, 3 [993/62,5468/63,8906/64] which had 
previously been called leiomyosarcomas met the criteria 
without difficulty. Another case [1001/62], previously called 
sarcoma NOS, whilst meeting the criteria for leiomyosarcoma, 
was situated in superficial dermis and 
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contained both 
inflammatory and nucleolated cells, and it was necessary to 
exclude melanoma by demonstration of negative 8100. Another 
case previously called sarcoma NOS (2538/61], likewise meeting 
leiomyosarcoma criteria to the extent that the diagnosis was 
thought highly probable, had, in addition, vascular stroma and 
a slightly haemangiopericytic appearance. Though it lacked 
epithelioid cells, clinical data supplied included reference 
to vascularity, and the differential therefore had to include 
malignant haemangiopericytoma. Factor 8 was negative and 
desmin positive, establishing the lesion as a vascular 
leiomyosarcoma of an extremity - a highly unusual tumour.13c 
In one other with a sweeping pattern, fibrillar-hyaline 
stroma, plump spindle cells and necrosis, which had been 
called a spindle-cell sarcoma [6347/63], leiomyosarcoma was 
favoured but monophasic synovial sarcoma was felt to enter the 
and presence of 
Calcification, 
diagnosis because of absence of giant cells, 
hypervascularity and inflammatory cells. 
however, was not a feature. IHC in this instance was 
unhelpful; although vimentin could be demonstrated, desmin 
posi ti vi ty for leiomyosarcoma and cytokeratin dot-posi ti vi ty 
for synovial sarcoma were both lacking. (The question of 
negative desmin results is addressed below). A diagnosis of 
leiomyosarcoma was eventually allocated, partly because of the 
necrosis and high mitotic index, but mostly because of the 
classic cigar-shaped nuclei. 
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A study of spindle-cell sarcomas with myofibroblastic 
differentiation has recently been published. 54 The following 
have been described and discussed: leiomyosarcoma of bone, 55 
the special features of smooth muscle tumours of the external 
genitalia,56 leiomyosarcomas of childhood,57 cutaneous and 
subcutaneous leiomyosarcomas.58 The issue of satisfactory 
markers for smooth and striated muscle has been constantly 
debated. Desmin and MSA (muscle-specific antigen) have been 
compared. 59 Reported incidences of desmin staining in 
malignant tumours of smooth and striated muscle are highly 
variable.60 Because of this, the role of desmin has been 
critically re-examined. It was shown that although all 
specimens of normal muscle and rhabdomyo(sarco)ma marked with 
desmin, 1 leiomyoma of 13 and 8 leiomyosarcomas of 2 6 did 
not, 60 which is of relevance to one of the cases discussed 
above. Of equal concern are the reports of apparent co-
expression of cytokeratin by smooth muscle cells. 61 A figure 
of 21% leiomyosarcoma positivity for cytokeratin has been 
reported,26 making this the most common sarcoma (except 
epithelioid and synovial sarcoma, where it is expected) to 
mark for cytokeratin, and thereby presenting a potential 
source of confusion. Miettinen quotes cytokeratin and EMA 
positivity in 42% and 60% of leiomyosarcomas respectively.62 
8. Rhabdomyosarcoma (Figs 5, 5.1, 5.3-6, 6) (4 cases). 
Pattern: disarranged (pleomorphic) 
disarranged/sweeping (embryonal) 
alveolar (alveolar). 
epithelioid (embryonal, alveolar) 
Stroma: vascular 
fibrillar (pleomorphic, alveolar) 
myxoid (embryonal, alveolar) 
Cells: slender spindle/granular epithelioid (pleomorphic, 
embryonal) 
strap-like (embryonal) 
plump spindle (pleomorphic) 
granular epithelioid (alveolar) 
Additional features: giant cells (pleomorphic), 
+/- cross-striations (embryonal) 
+/- glycogen/'spiderweb' cells 
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Of the 4 cases, 2 [ 9534/62, 8535/63] originally diagnosed 
as rhabdomyosarcomas met the criteria, being disarranged with 
myxoid stroma, strap-like cells and cross-striations, and were 
accepted as embryonal, of the botryoid subtype (subepithelial, 
cambium layer). 
Another case [5698/63] diagnosed as sarcoma NOS in each of 
its four separate presentations was, in the best specimen 
[ 2268/63], an embryonal rhabdomyosarcoma. No block for this 
specimen is available, and the other specimens were more 
difficult to be sure of, with some areas being myxoid and some 
fibrillary. 
tumours and 
In the differential between 






discounted (for lack of hyaline stroma). It was necessary to 
show positive MSA staining to resolve the question. (Desmin 
was twice negative). 
The fourth case (3327/61], diagnosed as sarcoma NOS, was 
densely cellular, vascular, with little stroma, and sweeping 
in pattern. Without stroma to classify as hyaline or myxoid, 
the differential diagnosis would have been wide (see Fig. 
5.3). However, the cells were in places strap-like, and PTAH 
stain showed a few with debatable cross-striations. Desmin was 
positive, though not emphatic, MSA acceptable. 
The question of poor results with desmin in some of these 
historic cases where muscle origin was firmly suspected has 
already been mentioned. Truong60 experienced no difficulty 
with desmin in relation to benign and malignant lesions of 
striated muscle. Another series reports reliability of the 
marker in 59 childhood rhabdomyosarcomas. 63 However, our own 
problems have been experienced elsewhere64 in relation to 
'very primitive rhabdomyosarcomas' . It is also probable that 
original fixation may hold part of the explanation in our 
cases, as pointed out in Chapter 2. A higher percentage (94%) 
of positive marking of rhabdomyosarcomas for desmin was 
obtained from cryostat sections than from formalin- or 
alcohol-fixed sections (77%) in another study, which noted 
better staining when the tissue was alcohol-fixed.65 (It also 
reported muscle antigen positivity in a variety of other 
unrelated lesions: Wilms' , 
neuroectodermal tumours, 
ossificans) 
rhabdoid and peripheral 




Other immunohistochemical work on striated muscle that is 
of interest concerns the distribution of actin isoforms in 
sarcomas,66 the expression of cytokeratin,67,68 and of s10068 
by rhabdomyosarcoma. A rather neat use of an antibody from 
myasthenic patients which can distinguish striated from smooth 
muscle has been reported.69 
Prognosis of rhabdomyosarcoma in children has been related 
to anaplasia.70 Pleomorphic rhabdomyosarcoma is said to be 
rare in adults over 30, and the diagnosis is more likely to be 
MFH or leiomyosarcoma. IHC is strongly advocated in such 
cases. 71 Miettinen, on re-examining 25 cases of adult 
rhabdomyosarcoma by IHC and EM, could confirm them in only 2 
( in accord with the instability noted for this diagnosis in 
adults as recorded in Tables 5 and 6), and he stresses the 
rarity of this tumour in patients over the age of 40. 72 A 
series of head and neck rhabdomyosarcomas in adults between 
the ages of 18 and 36 has been published.73 Rhabdomyosarcoma 
is the fourth commonest sarcoma of the oral/paraoral region 
(after osteo-, fibre- and chondrosarcoma) and the second 
commonest (after osteosarcoma) in patients under 20.74 
In experimentally-induced rhabdomyosarcoma, MFH-like areas 
have been seen, and the presence of MFH-like foci in well-
defined non-fibrohistiocytic sarcomas as evidence of de-
differentiation is being increasingly reported.75 
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[9.Malignant mesenchymoma (0 cases). 
This is a diverse and uncommon category, a minor part of 
which is two sarcomas (one generally being liposarcoma) 
comprising one lesion. More usually the term refers to a 
sarcoma (generally liposarcoma, 







osseous tissue, 13d No examples were seen in the re-examined 
historical material ( the one being so called originally was, 
on reassessment, thought to be more in keeping with myositis 
ossificans). 
Malignant mesenchymoma has recently been shown, rather 
surprisingly, to exhibit only low-grade behaviour.76] 
10. Synovial sarcoma (Figs 5, 5.3, 5.4, 5.6, 6) (5 cases) 
Pattern: alveolar-glandular/epithelioid (glandular 
component) 
sweeping (fibrous component) 
Stroma: fibrillar/vascular (glandular component) 
fibrillar/vascular/myxoid/hyaline (fibrous component) 
Cells: epithelioid (glandular component) 
plump/slender spindle (fibrous component) 
Additional features:+/- calcification 
+/- inflammatory cells (fibrous component) 
+/- haemangiopericytic ('staghorn') 
vessels 
combined glandular/fibrous features 
diagnostic of biphasic synovial sarcoma 
54 
Of the 5 cases, one was previously so called. This 
[5773/63] was an extremely interesting case occurring in the 
neck of a 30 year old woman. It certainly had the appropriate 
biphasic (but mainly glandular) appearance, with calcification 
moreover. However, the extremely papillary appearance of the 
markedly mucinous glandular component on re-assessment raised 
the question of metastatic adenocarcinoma and papillary 
thyroid carcinoma. But thyroglobulin IHC was negative (the 
strong positivity of CAMS. 2 and CEA were equally in accord 
with carcinoma and synovial sarcoma). An impressive workup had 
originally been carried out, in which it was shown that alcian 
blue-positive, hyaluronidase-sensitive material was mainly in 
the lumena rather than intracellular, which is a diagnostic 
feature of ss.13e 
Another case [4840/61], though predominantly spindled, and 
originally diagnosed as sarcoma NOS, had sparse glandular 
areas, making the diagnosis. Vimentin was positive, and 
cytokeratin weakly so. The EMA was not convincing because the 
glandular areas had been cut through on resectioning the 
block, leaving virtually only the spindled element. This, in 
contrast to the glandular component, is known to stain poorly 
with both epithelial markers. However, the diagnosis was felt 
secure on purely morphological grounds. Another [6869/64] was 
called a probable liposarcoma on postirradiation necrotic 
tissue, but an earlier specimen, diagnosed as sarcoma NOS, was 
confidently reassessed as a synovial sarcoma on the basis of 
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biphasic areas, in spite of secondary infection slightly 
masking this appearance. 
A third case ( 8084/62) had understandably been called a 
fibrosarcoma because of a sweeping pattern, hyaline stroma, 
plump spindle cells and necrosis, all features shared with 
monophasic fibrous synovial sarcoma. However, in review, the 
section was noted to be vascular (indeed, mimicking a vascular 
sarcoma in areas) and to contain inflammatory cells, raising 
the question of leiomyosarcoma, MPNST, monophasic fibrous 
synovial sarcoma and (more remotely, since there was no 
storiform pattern), MFH. Accordingly, an appeal was made to 
IHC. The vimentin and EMA were positive, desmin, AAT and S100 
negative, in agreement with a monophasic synovial sarcoma. 
A fourth case (6869/64] was extremely myxoid and had been 
irradiated. It was diagnosed as a probable liposarcoma, but an 
earlier biopsy showed a.glandular focus with epithelioid cells 
set in an otherwise spindled, vascular, somewhat fibrillar 
tumour containing numerous inflammatory cells. The areas with 
lacy pattern were attributed to fat entrapment. 
The last case [292/62], occurring in the spinal cord of a 
woman from whom a lesion said to be a melanoma had been 
removed from the shoulder some years before, had been 
previously diagnosed as MPNST, reasonably in view of the site 
and since it had the features of an epithelioid MPNST 
(fibrillar-vascular stroma) with plump and slender spindle 
cells, and epithelioid cells with a suggestion of rosette 
formation. Necrosis was present. However, bearing in mind the 
clinical 
biphasic 





was made of 
representing 
glandular differentiation. The IHC was interesting, because 
both SlOO and EMA were positive (though neither was strikingly 
so). SlOO positivity in both biphasic and monophasic tumours 
is documented77 and accordingly it was felt that this tumour 
was probably a biphasic synovial sarcoma, especially in view 
of the weak marking by S100. 
Synovial sarcoma has been reviewed,78 and the diagnostic 
problems posed by the fibrous 79 and epithelial 80 types when 
monophasic addressed. An intravascular form has been 
identified. 81 Prognostic factors have been reviewed, 82 and 
synovial sarcoma in children and adolescents considered.83 
The interrelationship between the biphasic and monophasic 
subtypes has been discussed.84 
[11. Malignant mesothelioma (Figs 5, 5.3, 5.4, 5.6, 6) 
(0 cases*) 
Pattern: alveolar-glandular/epithelioid (glandular component) 
sweeping (fibrous component) 
Stroma: fibrillar/vascular (glandular component) 
fibrillar/hyaline (fibrous component) 
Cells: granular epithelioid (glandular component) 
plump spindle (fibrous component) 
Additional features:+/- calcification 
+/- inflammation 
+/- necrosis 
+/- papillary formation, vacuolation, 
mucin lakes (glandular component) 
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(* This entity was specifically excluded from the study)] 
12. Clear cell sarcoma (Figs 5, 5.4, 5.5) (1 case) 
Pattern: epithelioid/lacy with nesting 
Stroma: myxoid/fibrillar/vascular 
Cells: clear epithelioid 
Additional features: glycogen 
+/- intracellular melanin 
+/- giant cells 
+/- necrosis 
Only 1 case [2482/63] was found, dating from a period five 
years before the first description of this class of sarcoma in 
1968. It had therefore correctly been called a Sarcoma NOS. It 
showed the classic features of clear cell sarcoma. Giant cells 
and necrosis were present, without intracellular melanin. SlOO 
was positive. 
Chromosomal abnormalities have been detected in 3 out of 3 
cases of clear cell sarcoma examined for them, but it is too 
early to say whether these are characteristic.BS The 




and a study of its prognostic factors 




Additional features: papillary 'tufting' into vascular spaces 
+/- necrosis 
The IHC and US of angiosarcoma of the face and scalp has 
been reviewed.90 An entity claimed to be distinctive, 
epithelioid angiosarcoma, which is allegedly often mistaken 
for an epithelial neoplasm, has been described,91 and 
angiosarcoma may arise in Kaposi's sarcoma.92 The IHC of 
angiosarcomas has been reviewed.93] 
14. Malignant haemangioendothelioma (Figs 5, 5.3, 5.4) 
(2 cases) 
Pattern: epithelioid (epithelioid form) 
sweeping>epithelioid (spindled form) 
Stroma: vascular/hyaline(sclerosed)/fibrillar (both forms) 
myxoid/(epithelioid form) 
Cells: epithelioid (epithelioid form) 
plump/slender spindled>epithelioid (spindled form) 
Additional features: 
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+/- intracellular vacuoles (both forms) 
cavernous spaces, vascular slits, 
inflammatory cells (spindled form) 
+/- phleboliths (spindled form) 
An example of each type was diagnosed. One (1887/63] had 
originally been called a Kaposi's sarcoma, 
with a sweeping pattern, predominantly 
vascular stroma, and scattered plasma 
slightly epithelioid appearance raised 
which it resembled, 
spindled cells and 
cells. However, a 
the possibility of 
angiosarcoma and haemangioendothelioma. The stroma was rather 
more hyaline than appropriate for angiosarcoma, and there was 
no tufting. The possibility of angioma had been entertained 
originally, because the slits were superficially rather 
cavernous, and in 1991, this was the feature which, even in 
the absence of phelobliths, favoured spindled 
haemangioendothelioma ( in which the epithelioid 
are to be expected). This entity was only 
1986.13f It has recently been claimed that 
neoplastic.94 Its co-occurrence with 
cells noted 
described in 
it is not 
epithelioid 
haemangioendothelioma has been described.95 Osteoclastic giant 
cells have been described associated with one lesion.96 
The other [4132/60] was thought to be a possible 
rhabdomyosarcoma at the time the leg in which it occurred was 
amputated. The only material now available was not diagnostic. 
60 
However, two preliminary biopsies (the block of one now 
unavailable) showed a vascular tumour with all the features of 
an epithelioid haemangioendothelioma, being of epithelioid 
pattern, with vascular /hyaline stroma, epithelioid ( somtimes 
vacuolated) cells. The appearance was classic, but 
confirmatory IHC was obtained from Factor 8 (desmin and 
cytokeratin were negative). This entity was only defined in 
1982.13g 
A Kaposi-like infantile haemangioendothelioma of the 
retroperitoneum has very recently been described for the first 
time. 97 
15. Kaposi's Sarcoma (Figs 5, 5.3, 6) (2 cases) 
Pattern: sweeping 
Stroma: vascular/myxoid/fibrillar 
Cells: plump/slender spindle 
Additional features: vascular slits 
inflammatory cells (lympho-/plasma-cytes) 
+/- necrosis 
+/- inclusions 
In both cases the original diagnosis was accepted on 
review. In one [ 8172/64 J, the vascular slits and mixture of 
spindle cells were classic, and the original diagnosis was 
understandably firm. In another [284/63), the spindled cells 
were very closely packed, and slits few, and the possibility 
of a spindle carcinoma was considered, though not the original 
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differential of fibrosarcoma (for which the stroma was 
insufficiently hyaline) . However, IHC showed the presence of 
vimentin and Factor 8 and the absence of cytokeratin, 
confirming the original tentative diagnosis. 
It has long been accepted that Kaposi's sarcoma is of 
endothelial origin, 98 but work continues to be published on 
the matter.18 
16. Malignant haemangiopericytoma (Figs 5, 5.2-4, 6) (2 cases) 
Pattern: sweeping/epithelioid/arranged (palisaded, storiform) 
Stroma: vascular/fibrillar/myxoid 
Cells: slender spindle/granular epithelioid 
Additional features: 'staghorn' vessels lined by a single 
layer of endothelial cells with basal 
lamina. 
dense reticulin network 
Both cases were so diagnosed originally. One [1696/62] was 
a classic example, of low-grade malignancy. The other 
[4044/61], though having a sweeping and palisaded arrangement 
in areas, and being prominently vascular, showed necrosis, and 
was particularly epithelioid, with a fibrillar appearance. 
Although there were myxoid areas, spindled cells were few, so 
that epithelioid MPNST and haemangioendothelioma entered the 
differential diagnosis. Against the latter, the endothelilal 
lining of the vascular spaces was single-layered. As with all 
epithelioid tumours where possible, an epithelial marker was 
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used to exclude carcinoma, and cytokeratin was indeed 
negative. So was desmin and Factor 8. Vimentin and S100 were 
positive. Haemangiopericytomas (soft tissue and meningeal)lOO 
are negative for Factor 8 (although occasional weak positivity 
has led to theories about intermediate forms between 
haemangiopericytoma and haemangioendothelioma).101 S100 
positivity is more unexpected, but has been described.102 
This case would have been the ideal subject of an 
ultrastructural study 
from MPNST, but on 
diagnosis was regarded 
to differentiate haemangiopericytoma 
morphological grounds, the original 
as probable because of the striking 
vascularity, ectasia, dense reticulin network and absence of a 
'buckled' appearance in the spindle-cell population. 
The IHC of peripheral haemangiopericytoma has been 
compared with its meningeal counterpart, meningioma and 
acoustic schwannoma,103 the distinct entity of sinonasal 
hemangiopericytoma reviewedl02, and hemangiopericytoma 
occurring in synovium described (of significance in view of 
the differential diagnosis of synovial sarcoma).104 
Familial occurrence of malignant haemangiopericytoma has been 
described.105 




Cells: giant/plump spindle/granular epithelioid 
Additional features:+/- calcification 
+/- necrosis 
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Extraskeletal osteosarcoma has been reviewect.106,107 The 
ultrastructural features of small-cell osteosarcoma have been 
describect.108] 
[18. Extraskeletal chondrosarcoma (Figs 5, 5.4. 5.5) (0 cases) 
Pattern: epithelioid/lacy 
Stroma: chondroid/myxoid 
Cells: granular & clear epithelioid 
Additional features: glycogen 
+/- calcification 
+/- multinodular pattern 
An extraskeletal mesenchymal chondrosarcoma has been 
reported in detai1.109] 
19. Malignant extraskeletal giant cell tumour (Giant cell MFH, 
malignant GCT of tendon sheath) (Figs 5. 5.2-4. 6) 
(1 possible case) 
Pattern: epithelioid/arranged/sweeping 
Stroma: fibrillar/vascular/hyaline 
Cells: giant/granular epithelioid/plump & slender spindle 
Additional features: storiform areas 
nodularity 
+/- inflammation, xanthoma cells 
+/- necrosis 
64 
No cases were diagnosed originally, since this rare entity 
had not benn delineated at the time. One case that had been 
called pleomorphic sarcoma [3489/62) was felt on reassessment 
to be 
blocks 
a malignant GCT, possibly 
are of superficial soft 
extraskeletal 
tissue) . Its 
(surviving 
striking 
vascularity was unaccompanied by any evidence of osteoid, 
which might have favoured a telangiectatic osteosarcoma. Bone 
was said to have been involved, but the location was in 
relation to the ankle in a 17 year old male, which would be an 
unusual site for a primary bone lesion. 
The ultrastructure and IHC of Malignant GCT and locally 
destructive pigmented villonodular synovitis have been 
reviewed.110 
20. Extraskeletal Ewing's sarcoma (Figs 5, 5.2, 5.4) (2 cases) 
Pattern: epithelioid/arranged (rosettes) 
Stroma: vascular/myxoid 
Cells: granular epithelioid ('small round cell tumour'-type) 




No cases were diagnosed originally. A case called sarcoma 
NOS (9633/64) was thought on review to be extraosseous Ewing's 
because of the suggestion of rosette formation in a 
predominantly epithelioid, lobulated tumour. The original 
report had considered but excluded embryonal rhabdomyosarcoma, 
but this diagnosis did not enter the review differential 
because the cells seemed insufficiently spindled. The absence 
of both spindling and a sweeping pattern also spoke against 
other (usually more obviously) rosetted species, amongst which 
the chief to be considered were the neural tumours (MPNST, and 
primitive neuroectodermal tumours - PNETs - which, outside the 
central nervous system are called neuroblastoma in ganglia and 
peripheral neuroepi thelioma or peripheral neuroectodermal 
sarcoma in peripheral nerve or soft tissue.111 Ewing's sarcoma 
is, however, now considered to be the most primitive form of 
neuroectodermal tumour,112 or at least closely related to 
it.113, 114 S100 is not always positive, and was negative in 
this case (as were EMA and desmin. Vimentin was positive). In 
confirmation of the diagnosis, intracellular glycogen was 
demonstrated. 
The other current example [5892/60) had been diagnosed as 
a poorly differentiated synovial sarcoma. On review, it 
resembled the first case, except that there was no impression 
of rosetting, and nesting was pronounced. There were no 
features in the sections seen to support a synovial sarcoma, 
and a diagnosis of Ewing's was made with confidence. 
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Subsequently, glycogen was demonstrated. Vimentin was weakly 
positive, cytokeratin, NSE and SlOO negative. 
The clinicopathologic features of 42 cases of extraosseous 
Ewing's sarcoma have been summarised.115 The issue of the 
immunohistochemistry of 'small round cell tumours' is a focus 
of contemporary activity in research.116,117,118 The IHC of 
neural adhesion molecules has been studiect.119 Childhood 
peripheral neuroepithelioma120 and small round cell tumours of 
the chest wa11121 have been the subject of clinicopathological 
reviews. Cell culture of one of the latter type of tumour has 
demonstrated clonal cytogenetic aberrations and suggested that 
the tumour may be derived from primitive and pleuripotential 
cells which differentiate to display mesenchymal, epithelial 
and neural features in variable proportion.122 
21. Malignant peripheral nerve sheath tumour 
(Figs 5, 5.1-4, 6) (7 cases) 
Pattern: arranged (palisaded, whorled,rosetted,plexiform)/ 
sweeping/epithelioid/disarranged (pleomorphic) 
Stroma: myxoid/vascular/hyaline/fibrillar 
Cells: 'wavy' plump & slender spindled/epithelioid (greatly 
predominant in uncommon epithelioid MPNST)/stellate 
67 
Additional features:+/- necrosis 
+/- nodular outline 
+/- heterologous elements (bone/cartilage) 
+/- giant cells (seldom) 
+/- rhabdomyoblasts (rare 'Triton' tumour) 
+/- glandular differentiation 
(in rare glandular MPNST) 
(Neurofibrosarcoma and malignant schwannoma are considered 
together as MPNST; there is no sharp interface. Malignant 
schwannoma has less, and neurof ibrosarcoma more, resemblance 
to a f ibroblastic lesion. A neurofibrosarcomatous appearance 
is associated with malignancy occurring in the context of von 
Recklinghausen's Disease). 
Of the 7 cases, only one [5412/63] was diagnosed 
originally. In this, the whorling was prominent, there were 
epithelioid and spindled cells, myxoid and hyaline areas. SlOO 
was confirmatorily positive. 
Another 4 cases had been called sarcoma NOS and one a 
fibrosarcoma. These on review were thought to satisfy the 
criteria for MPNST, especially with regard to fibrillary and 
myxoid stroma, and 'wavy' 
of shoals of fish 
[5468/61,4409/61,6721/62] 
cells (for which the usual metaphor 
is particularly apt). Three 
were low-, and one [3142/64] high 
grade. Positive S100 IHC confirmed the diagnoses, although in 
one case (a myxoid lesion occurring in the jaw of a 
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30 year old woman), there was initially some suspicion of an 
ameloblastic fibroma (though the odontogenic epithelium was 
not well defined). The reaction with S100 was modest, 
attributable either to poorly-preserved material or the known 
variability of expression of this antigen by MPNST. The sixth 
case [8897/60] was of interest because it seemed possible that 
it might be a Triton tumour, containing suspected 
rhabdomyoblasts in a very anaplastic sarcoma. A speculation 
about muscle origin made originally had been followed up with 
a PTAH stain, which showed no cross-striations. The tumour was 
poorly-preserved, and it was not surprising to find that 
desmin and S100 were negative. (MSA tried throughout the 
period of this study was an early commercial antibody and gave 
generally non-contributory labelling, as in this case. It was 
eventually abandoned). The diagnosis of MPNST therefore rests 
on morphology - chiefly the myxoid and fibrillary stroma in 
the absence of hyaline components. 
This absence of hyaline material in the seventh case 
seemed inconsistent with the original tentative diagnosis of 
fibrosarcoma [6882/60], although the pattern was sweeping and 
the cells spindled. But the stroma was fibrillary/myxoid, and 
although the material was not well preserved (the vimentin 
positivity was not outstanding), some of the tumour cells were 
SlOO-positive. 
Some emphasis 
group. Yet not 
has been placed on S100 staining in this 
all MPNST are S100-positive.13h It has 
nevertheless been concluded that it is a useful marker in all 
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nerve sheath tumours.123,124 The role of the perineurial cell 
in tumours has been receiving attention.125 The incidental 
involvement of perineurial cells in some lesions leads to EMA 
positivity, 126 and the 50% of MPNST which are SlOO-negative 
were supposed to be derived from perineurial cells. However, 
spindle-cell MPNST seems to be consistently EMA-negative, thus 
( fortunately) separating it from monophasic fibrous synovial 
sarcoma. 127 GFAP and cytokeratin expression has been noted, 
rarely, in MPNST, which may result in diagnostic 
difficulties.128,129 
A description has been given of the new entity of cellular 
schwannoma, which is pseudosarcomatous, and comes into the 
differential diagnosis of MPNST.130 Another unusual MPNST 
variant has been described as a 'malignant glandular triton 
tumour', having an adenocarcinomatous component added to 
rhabdomyoblastic elements in what was otherwise an MPNST.131 
MFH is speculated to be the final common pathway of a 
number of 'dedif ferentiated tumours' such as liposarcoma and 
leiomyosarcoma. A newly-described variation was 
morphologically a typical MFH but had the annulate lamellae 
characteristic of Schwann cells.132 MPNST has been shown 
capable of arising in ancient schwannoma,133 schwannoma,134 in 
ganglioneuroma,135 and following radiation for unrelated 
tumours.136 
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The clinicopathologic features of a series of 43 cases of 
MPNST of the buttock and lower extremity has been 
published.137 
[22. Malignant granular cell tumour (Figs 5, 5.6) (0 cases) 
Pattern: alveolar (nested) 
Stroma: fibrillar 
Cells: granular eosinophilic epithelioid 
Additional features:+/- necrosis 
Recent cases 
reported.138,139] 
+/- spindled areas 
of this rare· entity have 
23. Alveolar soft part sarcoma (Figs 5, 5.6). (3 cases) 
Pattern: alveolar (nested) 
Stroma: fibrillar/myxoid/vascular 
Cells: granular epithelioid 
Additional features: glycogen 
+/- prominent nucleolation 
+/- intracellular crystals 
+/- necrosis 
been 
This tends to be highly distinctive, and the two cases 
previously diagnosed were classic [953/63,8072/63]. 
The third case [5338/60] had been reported as a low-grade 
sarcoma NOS, with speculation about synovial and neural 
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origin. The cells were described as plump spindle. The 
pattern, however, was nested, initially suggesting a 
mitotically-active paraganglioma. This in interesting in view 
of the overlapping features of ASPS and paraganglioma noted in 
one other reported case.140 The absence of any hyaline stroma 
and the fact that the cells were more epithelioid than 
spindled was against synovial sarcoma (and in confirmation 
that this was not a synovial sarcoma, IHC for EMA was 
negative). Paraganglioma was excluded by a negative result 
with Grimelius stain, and IHC which showed no marking with 
chromogranin. SlOO was also negative, in refutation of neural 
origin. A positive stain for glycogen confirmed the diagnosis. 
Alveolar soft part sarcoma has recently been reviewed.141 
Theories of its derivation have invoked a number of origins, 
including neural crest, paraganglia and skeletal muscle.138 
Most IHC studies favour rhabdomyoblastic 
differentiation.142,143,144,145,146 
II RENAL SARCOMA. 
Clear cell sarcoma of kidney (l possible case) 
This [3284/60] was a paravertebral tumour in an adolescent 
female for which the eminently reasonable suggestion of 
neurofibrosarcoma had been made. Some areas of the tumour were 
nested/alveolar, and others sweeping. The cells were spindled 
and stellate, and with hyalinised pseudorosettes in the nested 
area, in accord with the original diagnosis. However, in the 
nested areas, there were many strikingly clear cells with 
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vesicular, round nuclei and indistinct nucleoli. Strama was 
fibrillar and strikingly vascular. Necrosis was present. 
Differential diagnoses considered were ependymal and yolk sac 
tumour. However, though vimentin was positive, EMA, CAM5.2, 
S100 and GFAP were negative, as were mucin and PAS stains. 
This is tentatively reclassified as a clear cell sarcoma of 
the kidney, 147 which would also be more in keeping with the 
age of the patient. Significantly in the context of the 
morphology, it has been hypothesised, because of the light 
microscopic appearances, that the Schwann cell may be the cell 
of origin, but this has not withstood ultrastructural 
investigations. 
III LESIONS EXCLUDED AS NON-SARCOMATOUS 
Of these cases, doubts concerning a sarcomatous nature had 
been expressed in 7 of them originally. 
a) Carcinomas (3 cases) 
Three spindle cell carcinomas were identified. Two, from 
the lip [2570/62], and from the tongue [9463/61] were 
interesting, and illustrate a difficulty which is self-
evidently not altogether rare. They had been called probable 
sarcomas NOS, and indeed, on reassessment, leiomyosarcoma was 
thought to be a possibility in the first case, and pleomorphic 
rhabdomyosarcoma in the case of the second. However, in both, 
desmin was negative, although vimentin was positive. More 
significantly, epithelial markers (cytokeratin used in one 
case, CAM5.2 in the other) were strongly positive. Although 
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carcinosarcoma has been a term employed for such situations, 
it is felt better to reserve it for lesions in which there is 
evidence of the bimodal coexistence of carcinoma and sarcoma 
( in which the one cannot be seen arising from the other). 
However, in both, the surface epithelium was dysplastic and 
merged by degrees with the deeper 'sarcomatous' vimentin-
positive component, spindled in one case and pleomorphic in 
the other. Accordingly the lesions were classed as carcinoma 
( coexpressing vimentin 'metaplastic carcinoma' would be a 
suitable term), which also seemed more appropriate to the site 
in the case of the lip. Had the morphological progression of 
one element into the other not been apparent, these would have 
been two more apparent possible examples of cytokeratin 
expression by sarcomas, which is the cause of some 
contemporary controversy as has already been pointed out, 26 
and which the semantic difficulties related to the term 
'carcinosarcoma' do nothing to lessen. A third case [5088/63] 
from the dorsum of a hand was diagnosed originally as a 
malignant connective tissue tumour. It apparently arose from 
overlying epidermis, and the cells were plump and nucleolated. 
Although it was thought unnecessary, positive epithelial and 
(in contrast to the previous cases) negative vimentin marking 
was exhibited. 
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b) Miscellaneous (7 cases) 
The remainder of lesions not finally classified as 
sarcomas on re-assessment can be dealt with briefly. 
Two myxomatous lesions originally thought to be at least 
'locally malignant' [ 5921/62, 8882/62] had no lipoblastic 
activity, and were reassigned as myxomata, one corresponding 
to an intramuscular myxoma and the other to a myxoma of the 
jaw .13i 
One low-grade spindle-cell lesion for which neural or 
smooth-muscle origin were originally proposed [3887/62] was a 
neurilemmoma (Schwannoma), the features causing disquiet about 
possible local recurrence being those due to 'ancient' changes 
of degenerative nuclear atypia with increased vascularity, and 
sparse psammomatous calcification.13j 
There were two examples of 
originally thought to be a probable 
myxosarcoma. The first [8433/64] 
nodular fasciitis, one 
sarcoma and the other a 
consisted of spindled, 
stellate and epithelioid cells in a disarra,nged pattern that 
varied from dense to loose and 'feathery'. The stroma was 
fibrillar, vascular ( some of the vessels having very thick 
walls) and focally very myxoid, with numerous inflammatory 
cells, xanthoma cells, microcysts and calcification (the 
diagnosis of neurofibroma or fibromatosis was made on an 
excision biopsy in 1965). IHC for SlOO, CAM5.2 and desmin was 
negative. The second [5786/64] was like the first except in 
lacking epithelioid and xanthoma cells, and calcification, but 
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showing keloid-like collagen which is another feature of 
nodular fasciitis. 
A lesion [3663/61] stated to be either a pseudosarcoma or 
a fibrous tissue tumour not likely to behave in more malignant 
fashion than DFP was on reassessment called proliferative 
myositis with confidence. It had sweeping and disarranged 
patterns, with epi- and endomysial proliferation of spindled, 
epithelioid and giant cells. Stroma was fibrillar and hyaline, 
and the appearance classic. 
Another lesion [2808/64) called a mixed mesodermal tumour 
of very low grade local malignancy, was on reassessment 
thought to be myositis ossificans. It had a disarranged 
pattern and consisted of spindled, stellate and epithelioid 
cells, with fibrillar, 
areas of necrosis and 
inflammation was present. 
vascular and hyaline stroma showing 
bone formation. Low-grade background 
CHAPTER6 
A MORPHOLOGICAL APPROACH TO THE 
CATEGORISATION OF SARCOMAS 
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The subdivision of sarcomas into diagnostic entities is 
rich in scope. It provides pathologists with taxonomic 
fascination and debate, and is in a constant state of flux, 
the more so since the advent of IHC, which has raised as many 
questions as it has answered. Two important major contemporary 
texts by Enzinger & Weiss13a and by Hajdu148 cover the subject 
of sarcoma morphology. This dissertation has been concerned 
with 24 diagnostic categories from SNOMed, and even so, is by 
no means exhaustive. Within several, such as MFH, 
rhabdomyosarcoma, liposarcoma, are subcategories. A major 
group, the mesotheliomas, and several minor ones classified as 
sarcomas by Enzinger & Weiss ( neuroectodermal tumours, 
(ganglio)neuroblastoma, chordoid sarcoma [chordoma], malignant 
paraganglioma) and by Hajdu ( ependymoma, chordoma, myeloma, 
granulocytic sarcoma) have been ignored. The reasons for doing 
so have been explained in Chapter 2. 
In order to facilitate comparisons, it was felt important 
to reach a specific diagnosis if at all possible, even if 
reservations (indicated in the tabulated material by a 
question mark) existed. It became necessary to try and 
standardise diagnostic criteria, both to validate the 
comparisons being made, and as an exercise in itself. The art 
of diagnosis is one of comparing patterns. The steps suggested 
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to take place, not always consciously, are: aggregation of 
groups of findings into patterns, selection of a key finding, 
selection of a diagnosis and validation of the diagnosis by 
reference to the clinical data provided, in which site and age 
are of greatest importance - aetiology is practically never a 
factor since little is known about it. A rather similar 
sequence of processes has been proposed for clinical 
diagnosis.149 The assessment of a histological slide presents 
the pathologist with myriad detail, and the first task is to 
reduce the size of the problem by combining sets of elementary 
findings into aggregate findings, taking advantage of a 
hierarchical approach. The next step is to generate a list of 
differential diagnoses, and then to prune it by comparing the 
known features of each with what is seen. From the final 
short-list, the items are compared two-at-a-time for their 
ability to explain the observations. 
Hajdu148 constructed tables of histological patterns, cell 
morphology, and stromal appearances for the sarcomas, and 
these were the starting-point for the Venn diagrams of this 
Chapter. Tables do not easily show multifactorial 
relationships between tumours, and each item of information 
can only be taken one-at-a-time, so that using data in this 
form to generate a list of differential diagnoses is a 
labyrinthine process. The power of a Venn diagram, consisting 
of circles each representing a particular property and 
containing the names of items which possess that property, is 
its ability to group data clearly, manageably and on multiple 
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levels simultaneously. Where the circles intersect, items 
within the overlapped areas show the properties of each of the 
circles making up the overlap. Thus, in the diagram of pattern 
combinations Fig. 5), haemangiopericytoma is easily seen to 
possess potentially not only the 'sweeping' pattern commonly 
associated with it, but also to have a capacity for an 
'arranged' pattern and an 'epithelioid' pattern, and more 
importantly, to resemble MPNST and GCT in this respect. In the 
diagram of spindle cell morphology, only a few tumours are 
characterised as uniquely plump-celled, and rather more as 
uniquely slender-celled; more complex are the major groups of 
sarcoma which show both features. 
This system has been validated against the re-examined 
cases of this dissertation, and against other cases. It is 
still susceptible to modification and refinement, but has been 
shown to lead quickly and reasonably accurately to appropriate 
differential diagnoses. One must first decide whether the 
lesion is a neoplasm at all, and then whether benign or 
malignant. The ordinary classical criteria are followed: 
presence of atypical mitoses, high cellularity, necrosis, 
cellular pleomorphism and pushing or infiltrating margins all 
favour malignancy. Next, the sometimes difficult decision has 
to be made as to whether the malignant tumour is a sarcoma 
(i.e. truly of mesenchymal origin). With increasing frequency, 
this requires arbitration by IHC, and even then (with a 
frequency rather less increasing), ambiguity is still 
possible. 
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Having decided that a sarcoma must be retained in the list 
of possibilities, the first decision to be made, following 
Hajdu, is taken at lowest power magnification: which of six 
Architectural Pattern(s) does the case in hand exhibit (Fig 
5)? None of them is uniquely diagnostic, even when overlapping 
patterns (second-order complexity) are considered. The 
Patterns are self-evident. The 'lacy' consists of a web-like 
network, the 'alveolar/glandular' of aggregates within septae, 
the 'epithelioid' of densely-packed cells appearing to adhere 
to one another, the 'sweeping' of sheets of cells which tend 
to align in the same direction, if only for short distances, 
the 'arranged' of any kind of uniformity within which there is 
subordering (of which, obvious examples are the storiform 
nebulae seen in most MFH and the palisading in some malignant 
schwannomas). If no regularity at all can be perceived, the 
pattern is 'disarranged'. 
Having decided on the Pattern, each one generates a 
subsidiary Venn diagram (Figs 5.1-5.6). In these, a feature is 
assessed for which higher power magnification is required, 
namely, the stroma of the tumour. Five types: fibrillar, 
hyaline, myxoid, vascular, and chondrified show important 
discriminatory power. 
fibres of collagen 
(Fibrillar stroma consists of the fine 
III that would stain with reticulin. 
Hyaline stroma is the coarser collagen I which Masson's 
Trichrome can be used to emphasise). 
At this point, the differential list will, under optimum 
conditions, have become more manageable, and further narrowing 
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will require ancilliary features to be sought. These include 
cellular morphology (spindle [Fig 6], epithelioid, giant), the 
presence of necrosis, calcification, inflammatory cells, 
staghorn vessels, cellular inclusions and so forth. Ideally, a 
unique diagnosis should be possible. If not, as is often the 
case, IHC and EM become necessary. 
It cannot be too strongly emphasised that the process 
described is no more than useful for a provisional diagnosis. 
It does not at all eliminate the need for careful evaluation 
of the histology against the published description of the 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































INDEX TO PLATES 
(The Plates Illustrate Morphological Terms Employed 
in Figures 5. Historical Material as Re-evaluated 
Has Been Used Wherever Possible). 
Alveolar Plate 1 (ASPS) 
Arranged: 
Herringbone Plate 2 (Fibrosarcoma) 
Palisaded Plate 3 (MPNST) 
Plexiform Plate 4 (MPNST) 
Rosettes Plate 5 (Ewing's Sarcoma) 
Storiform Plate 6 (DFP) 
Whorled Plate 7 (MPNST) 
Biphasic Plate 8 (SS) 
Disarranged Plate 9 (MPNST) 
Epithelioid Plate 10 (Epithelioid Sarcoma) 
Fibrillar Plate 11 (MPNST) 
Hyaline/Sclerosed Plate 12 (SS) 
Lacy Plate 13 (Liposarcoma) 
Myxoid Plate 14 (Spindle Cell Sarcoma NOS) 
Osteoid Plate 15 (Extraskeletal Osteosarcoma) 
Spindle Cells Plate 16 (MPNST) 
sweeping Plate 17 (MPNST) 
Vascular Plate 18 (Spindle Cell Sarcoma NOS) 
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PLATE 1 ALVEOLAR 
(Alveolar Soft Part sarcoma) 




PLATE 3 ARRANGED - PALISADED 
(Malignant Peripheral Nerve Sheath Tumour) 
PLATE 4 ARRANGED - PLEXIFORM 
(Malignant Peripheral Nerve Sheath Tumour) 
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PLATE 5 ARRANGED - ROSETTES 
(Ewing's Sarcoma) 
PLATE 6 ARRANGED - STORIFORM 
(Dermatofibrosarcoma Protuberans) 
93 
PLATE 7 ARRANGED - WHORLED 
(Malignant Peripheral Nerve Sheath Tumour) 
PLATE 8 BIPHASIC 
(Synovial Sarcoma) 
94 
PLATE 9 DISARRANGED 
(Malignant Peripheral Nerve Sheath Tumour) 
PLATE 10 EPITHELIOID 
(Epithelioid Sarcoma) 
95 
PLATE 11 FIBRILLAR 
(Malignant Peripheral Nerve Sheath Tumour) 
PLATE 12 HYALINE/SCLEROSED 
(Synovial Sarcoma) 
96 
PLATE 13 LACY 
(Liposarcoma) 
PLATE 14 MYXOID 
(Spindle Cell Sarcoma NOS) 
97 
PLATE 15 OSTEOID 
(Extraskeletal osteosarcoma) 
PLATE 16 SPINDLE CELLS - PLUMP & SLENDER 
(Malignant Peripheral Nerve Sheath Tumour) 
98 
PLATE 17 SWEEPING 
(Malignant Peripheral Nerve Sheath Tumour) 
PLATE 18 VASCULAR 




A reinvestigation, almost entirely by morphology as 
determined by light microscopy, but with IHC supplementation 
where indicated and possible, has been undertaken into a 
modest historical series of sarcomas of approximately thirty 
year vintage. Clinico-pathological correlations were expressly 
not sought. A supplementary aspect of the survey has been the 
presentation of subsequent statistics of sarcoma diagnosis 
within a large Southern African pathological practice which 
has had the privilege to act as a referral centre, and whose 
experience, for that reason, has been wide though possibly not 
typical. A comparison of the findings in this context with 
those of centres elsewhere in the world has shown some minor 
idiosyncrasies, but an overall resemblance. The broadest 
conclusion to be drawn from the exercise is that the 
difficulties encountered in this field are principally 
nosological, i.e. related to flux of diagnostic criteria and 
to the burgeoning description of new entities (which, it may 
be observed, appears to be undergoing a current growth phase). 
It should also be remarked that, without a demonstration of 
idiosyncratic clinical behaviour, the description of a new 
entity is to a large extent sterile. If two sarcomas have the 
same prognosis and response to therapy, a nosological 
separation because of subtle morphological differences is 
academic, and there is a distinct impression that this may be 
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the case with many currently-described exotica. Yet this is 
not entirely true; post hoc propter hoc, the recognition of 
clinically deviant behaviour and response to therapy are 
probably not always the first things to be noted, but 
sometimes the last. 
This study has generated a recommendation for future 
reporting, namely that: 
not only the macroscopic description of the specimen 
but the number of blocks taken and the procedures to which 
they are subjected be scrupulously recorded. The blocks should 
be individually identified by labelling at the time they are 
taken from the bulk specimen, and, if the specimen is 
macroscopically inhomogeneous, the labels incorporated into 
the macroscopic description. 
the microscopic description of diagnostic features 
not readily discerned in the majority of blocks be similarly 
recorded and at least one representative block be identified 
in each case. 
the report should terminate with an explicit list, in 
words, of at least the topographical and morphological SNOMed 
codes under which it is to be recorded. These may lie anywhere 
in the spectrum between the specific or the non-specific, but 
will represent in every case no less than the diagnostic limit 
to which the pathologist is prepared to commit himself. (Very 
similar proposals, among others, have recently been made 
independently by the Association of Directors of Anatomic and 
Surgical Pathology).150 
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Finally, arising out of this study, a practical scheme for 
the preliminary categorisation of a sarcomatous lesion is 
presented, which it is hoped winnows key features, enabling 
the pathologist whose everyday experience does not include 
these fascinating neoplasms to arrive more speedily at a 




1 H.T. Enterline, Histopathology of Sarcomas, Seminars in 
Oncology, 1981, ~' 133-53. 
2 L Angervall, L.-G. Kindblom, A. Rydholm & B. Stener, The 
Diagnosis & Prognosis of Soft Tissue Tumours, Seminars in 
Diagnostic Pathology, 1986, J, 240-58. 
3 s. Leyvraz & J. Costa, Issues in the Pathology of Sarcomas 
of Soft Tissue & Bone, Seminars in Pathology, 1989, 1.Q., 273-
80. 
4 F.R. Eilber, J.F. Huth, J. Mirra et al, Progress in the 
Recognition & Treatment of Soft Tissue Sarcomas, Cancer, 1990, 
65, 660-6. 
5 J.E. Cooper & P.W. Allen, Low-Grade Sarcomas, Path.Annual, 
1990 (2), 1-18. 
6 J. Ross, M.R. Hendrickson & R.L. Kempson, The Problem of 
the Poorly-Differentiated Sarcoma, Seminars in Oncology, 1982, 
-2_, 467-81. 
7 H. Hashimoto, Y. Daimaru, M. Tsuneyoshi et al, Soft Tissue 
Sarcoma with Additional Anaplastic Components, Cancer, 1990, 
il, 1578-89. 
8 J.-M. Coindre, N.B. Bui, F. Bonichon et al., 
Histopathologic Grading in Spindle Cell Soft Tissue Sarcomas, 
Cancer, 1988, .Q.l, 2305-9. 
9 R.B. Raney, M. Tefft, H.M. Maurer et al., Disease Patterns 
& Survival Rate in Children with Metastatic Soft-Tissue 
Sarcoma, ibid., 1988, .Q.2., 1257-66. 
10 w. Ruka, L.J. Emrich, D.L. Driscoll et al., Prognostic 
Significance of Lymph Node Metastasis & Bone, Major Vessel or 
Nerve Involvement in Adults with High-Grade Soft Tissue 
Sarcomas, ibid., 999-1006. 
11 C. Fisher, The Value of EM and IHC in the Diagnosis of 
Soft Tissue Sarcomas, Histopath., 1990, 1.Q., 441-54. 
12 J.A. Fletcher, H.P. Kozakewich, F.A. Hoffer et al., 
Diagnostic Relevance of Clonal Cytogenetic Aberrations in 
Malignant Soft-Tissue Tumours, New England J.Med., 1991, 324, 
436-42. 
13a F.M. Enzinger & s.w. Weiss, Soft Tissue Tumors, 2nd 
edition, C.V. Mosby, St Louis, 1988,. 
13b ibid., 562 
13c ibid., 417 
13d ibid., 958 
13e ibid., 677 
103 
13f ibid.' 538 
13g ibid.' 532 
13h ibid.' 786 
13i ibid.' 912, 920 
13j ibid.' 734 
14 F.M. Enzinger & s.w. Weiss, MFH: An Analysis of 200 Cases, 
Cancer, 1978, 41, 2250-66. 
15 L.P. Dehner, MFH: Nonspecific Morphologic Pattern, 
Specific Sarcoma Entity or Both?, Arch.Path.Lab.Med., 1988, 
112, 236-7. 
16 z. Ruszczak, A. Mayer-Da Silva & C.E. Orfanos, Kaposi's 
Sarcoma in AIDS, Am.J.Dermatopath., 1987, 2, 388-98. 
17 J Armes, A Review of Kaposi's Sarcoma, Adv.Cancer Res., 
1989, -5.]., 73-87. 
18 C. Kraffert, L. Planus & N.S. Penneys, Kaposi's Sarcoma: 
Further IHC Evidence of a Vascular Endothelial Origin, 
Arch.Dermatol., 1991, 127, 1734-5. 
19 M. Dictor & N. Bendsoe, Transmissible Agent of Kaposi's 
Sarcoma, Lancet, 1990, 335, 797 and refs. therein. 
20 T.A. Alvegard & N.O. Berg, Histopathology Peer Review of 
High-Grade Soft Tissue Sarcoma, J.Clin.Oncol., 1989, 1, 1845-
51. 
21 M. Shiraki, H.T. Enterline, J.J. Brooks et al., Pathologic 
Analysis of Advanced Adult Soft Tissue Sarcomas, Bone Sarcomas 
and Mesotheliomas, Cancer, 1989, 64, 484-90. 
22 R.B. Nagle, Intermediate Filaments, Am.J.Clin.Path., 1989, 
21, Suppl. 1, Sl4-18. 
23 A.S. Leong & J. Wright, The Contribution of IHC Staining 
in Tumour Diagnosis, Histopath., 1987, 1.l, 1295-1305. 
24 K.C. Gatter, D.Y. Mason, E. Heyderman et al., Which 
Antibodies for Diagnostic Pathology?, .il2.id., 661-4. 
25 G. Mechtersheimer, Towards the Phenotyping of Soft Tissue 
Tumours by Cell Surface Molecules, Virchows Archiv A, 1991, 
419, 7-28. 
26 P.E. Swanson, Heffalumps, Jagulars & Cheshire Cats, 
Am.J.Clin.Path., 1991, -22, Suppl. 1, S2-7. 
27 M. Leader, M. Collins, J. Pastel et al., Vimentin: an 
Evaluation of its Role as a Tumor Marker, Histopath., 1987, 
ll, 63-72. 
104 
28 C.D. Gerharz, A Moll, P. Meister et al., Cytoskeletal 
Heterogeneity of an Epithelioid Sarcoma, Arn,J.Surg.Path., 
1990, 1.4., 274-83. 
29 W.M. Molenaar, B. DeJong, A. Darn-Meiring et al., 
Epithelioid Sarcoma or Malignant Rhabdoid Tumour of Soft 
Tissue?, Hurn.Path., 1989, 20, 347-51. 
30 A.E. Rosenberg, J.E. Garber, W. Bennett et al., 
Epithelioid Sarcoma with Diffuse Bone Marrow Metastases and 
Associated Leukaernoid Reaction, Arn.J.Clin.Path., 1988, 90, 
723-6. 
31 S.M. Scott, H.M. Reimann, D.J. Pritchard et al., Soft 
Tissue Fibrosarcornas, Cancer, 1989, 64, 925-31. 
32 P.Meister, N. Hohne, E. Konrad et al., Fibrous 
Histiocytorna: An Analysis of the Storiforrn Pattern, Virchows 
Archiv A, 1979, 383, 31-41. 
33 C.D.M. Fletcher, MFH?, Histopathology 1987, 1.1, 433-7. 
34 s.w. Weiss, G.L. Bratthauer & P.A. Morris, Postirradiation 
MFH Expressing Cytokeratin, Arn.J.Surg.Path., 1988, 11, 554-8. 
35 T. Hirose, E. Kudo, T. Hasegawa et al., Expression of 
Intermediate Filaments in MFH, Hurn.Path 1989, 20, 871-7. 
36 c.w. Lawson, C. Fisher & K.C. Gatter, An 
Irnrnunohistochernical Study of Differentiation in MFH, 
Histopath. 1987, 1.1, 375-83. 
37 M. Miettinen & Y. Soini, MFH: Heterogeneous Patterns of 
Intermediate Filament Proteins by IHC, Arch.Path.Lab.Med., 
1989, 113, 1363-6. 
38 M.J. Costa & S.W. Weiss, Angiornatoid MFH, Arn,J,Surg.Path., 
1990, 1.4., 1126-32. 
39 C.D.M. Fletcher, Angiornatoid MFH - an IHC Study Indicative 
of Myoid Differentiation. Hurn.Path., 1991, 22, 563-8 
40 M.E.F. Smith, M.J. Costa & S.W. Weiss, Evaluation of CD68 
and Other Histiocytic Antigens in Angiornatoid MFH, 
Arn.J.Surg.Path., 1991, 1.5., 757-63. 
41 A. Beharn & C.D.M. Fletcher, Atypical Pseudosarcornatous 
Variant of Cutaenous Benign Fibrous Histiocytorna, Histopath., 
1990, .11, 167-9. 
42 H.K.Wolf, J.M. Harrelson & E.H. Bossen, Multicentric MFH 
of Soft Tissue, Arn.J.Surg.Path., 1990, 1.4., 188-93. 
43 R.J. Zehr, T.W. Bauer, K.E. Marks et al., Ki-67 and 
Grading of MFH, Cancer, 1990, QQ, 1984-90. 
105 
44 B. Rooser, H. Willen, P. Gustafson et al., MFH of Soft 
Tissue: a Population-based Epidemiologic & Prognostic Study of 
137 Patients, Cancer, 1991, ~, 499-505. 
45 J Ding, H Hashimoto & M Enjoji, DFP with Fibrosarcomatous 
Areas, Cancer, 1989, 64, 721-9. 
46 J.M. Lopes & M.E. Paiva, DFP: A Histological And 
Ultrastructural Study, Path.Res.Pract., 1991, 187, 806-13. 
47 S.S. Banerjee, M Harris, B.P. Eyden et al., Granular Cell 
Variant of DFP, Histopath., 1990, ll, 375-8. 
48 B.M. Schmookler, F.M. Enzinger & S.W. Weiss, Giant Cell 
Fibroblastoma, Cancer, 1989, 64, 2154-61. 
49 A. Alguacilgarcia, Giant Cell Fibroblastoma Recurring as 
DFP, Am.J.Surg.Path., 1991, 1.5., 798-801. 
50 A. Beham & C.D.M. Fletcher, DFP with Areas Resembling 
Giant Cell Fibroblastoma, Histopath., 1990, ll, 165-7. 
51 H. Kamino & M. Jacobson, Dermatofibroma Extending into the 
Subcutaneous Tissue, Am.J.Surg.Path., 1990, 14, 1156-64. 
52 N. Azumi, J. Curtis, R.L. Kempson & M.R. Henrickson, 
Atypical and Malignant Neoplasms Showing Lipomatous 
Differentiation, Am.J.Surg.Path., 1987, .ll., 161-83. 
53 H.R. Chang, S.I. Hajdu, c. Collin et al., The Prognostic 
Value of Histologic Subtypes in Primary Extremity Liposarcoma, 
Cancer, 1989, 64, 1514-20. 
54 B.P. Eyden, S.S. Banerjee, M. Harris et al., A Study of 
Spindle Cell Sarcomas Showing Myofibroblastic Differentiation, 
UltrastructPath., 1991, 1.5., 367-78. 
55 M.P.A. Young & A.J. Freemont, Primary Leiomyosarcoma of 
Bone, Histopath., 1991, 1.2., 257-62. 
56 P.L. Newman & C.D.M. Fletcher, Smoooth Muscle Tumours of 
the External Genitalia, Histopath., 1991, 18, 523-9. 
57 P.E. Swanson, M.R. Wick & L.P. Dehner, Leiomyosarcoma of 
Somatic Soft Tissue in Childhood, Hum.Path., 1991, 22, 569-77. 
58 G.F. Oliver, H.M. Reiman, N.J. Gonchoroff et al., 
Cutaneous & Subcutaneous Leiomyosarcoma, Brit.J.Dermatol., 
1991, 124, 252-7. 
59 S. Rangdaeng & L.D. Truong, Comparative IHC Staining for 
Desmin and MSA, Am.J.Clin.Path., 1991, .2..6., 32-45. 
106 
60 L.D. Truong, s. Rangdaeng, P. Cagle et al., Diagnostic 
Utility of Desmin, Am,J.Clin.Path., 1990, .2.1, 305-14. 
61 B.A. Gusterson, Is Keratin Present in Smooth Muscle?, 
Histopath., 1987, 1.1, 549-52, and references therein. 
62 M. Miettinen, Immunoreactivity for Cytokeratin and EMA in 
Leiomyosarcoma, Arch.Path.Lab.Med., 1988, ..l.12., 637-40. 
63 s. Dodd, M. Malone & w. McCulloch, Rhabdomyosarcoma in 
Children, J.Path., 1989, 158, 13-8. 
64 R.L. Carter, K.P. McCarthy, L.G. Machin et al., Expression 
of Desmin and Myoglobin in Rhabdomyosarcomas and in Developing 
Skeletal Muscle, Histopath., 1989, 15, 585-95. 
65 D.M. Parham, B. Webber, H. Holt et al., IHC of Childhood 
Rhabdomyosarcomas and Related Neoplasms, Cancer, 1991, 67, 
3072-80. 
66 P.J.M. Roholl, H.R.J. Elbers, I. Prinsen, et al., 
Distribution of Actin Isoforms in Sarcomas, Hum.Path., 1990, 
2..1, 1269-74. 
67 M Miettinen, Immunohistochemical Spectrum of 
Rhabdomyosarcoma and Rhabdomyosarcoma-like Tumors, 
Am.J.Surg.Path., 1989, ..l]., 120-32. 
68 J.M. Coindre. A. De Mascarel, M. Trojani et al., 
Immunohistochemical Study of Rhabdomyosarcoma: Unexpected 
Staining with SlOO Protein and Cytokeratin, J.Path., 1988, 
155, 127-32. 
69 A. Om & T. Ghose, Use of Anti-Skeletal Muscle Antibody 
from Myasthenic Patients in the Diagnosis of Childhood 
Rhabdomyosarcomas, Am.J.Surg.Path., 1987, 1.1, 272-6. 
70 H.H. Hawkins & J.V. Camacho-Velasquez, Rhabdomyosarcoma in 
Children, Am.J.Surg.Path., 1987, 11, 531-42. 
71 A.S.H. De Jong, M. van Kessel-van Vark & C.E. AlbusLutter, 
Pleomorphic Rhabdomyosarcoma in Adults, Hum.Path., 1987, l.e., 
289-303. 
72 M. Miettinen, Rhabdomyosarcoma in Patients Older than 40 
Years of Age, Cancer, 1988, .[2, 2060-5. 
73 R.E. Nakhleh, P.E. Swanson & L.P. Dehner, Juvenile 
(Embryonal and Alveolar) Rhabdomyosarcoma of the Head and Neck 
in Adults, Cancer, 1991, 9J..., 1019-24. 
74 E. Peters, M. Cohen, M. Altini et al., Rhabdomyosarcoma of 
the Oral and Paraoral Region, Cancer, 1989, .§.1, 963-6. 
107 
75 H. Kosmehl, L. Langbein & D. Katenkampf, Experimental 
Rhabdomyosarcoma with Regions Like MFH, J.Path. 1990, 160, 
135-40. 
76 P.L. Newman & C.D.M. Fletcher, Malignant Mesenchymoma -
Clinicopathological Analysis of a Series, Am.J.Surg.Path., 
1991, 1.5., 607-14. 
77 c. Fisher & J.B. Scofield, SlOO-Positive Synovial Sarcoma, 
Histogath., 1991, 1.2., 375-7. 
78 G.R. Dickersinn, Synovial Sarcoma - a Review and Update, 
with Emphasis on the Ultrasctructural Characterisation of the 
Nonglandular Component, Ultrastruct.Path., 1991, 1.5., 379-402. 
79 N.G. Ordonez, S.M. Mafouz &·B. Mackay, Synovial Sarcoma, 
an IHC and US Study, Hum.Path, 1990, 21., 733-49. 
80 R.M. Majeste & E.N. Beckman, Synovial Sarcoma with an 
Overwhelming Epithelial Component, Cancer, 1988, .2.1, 2527-31. 
81 M. Miettinen, S. Santavirta & P. Slatis, Intravascular 
Synovial Sarcoma, Hum.Path. 1987, 1]., 1075-7. 
82 B. Rooser, H. Willen, A. Hugoson et al., Prognostic 
Factors in synovial Sarcoma, Cancer, 1989, 63, 2182-5. 
83 D. Schmidt, P. Thum, D. Harms et al., Synovial Sarcoma in 
Children & Adolescents, Cancer, 1991, &.J.., 1667-72. 
84 I. Dardick, S. Ramjohn, M.J. Thomas et al., Synovial 
Sarcoma - Interrelationship of Biphasic and Monophasic 
Subtypes, Path.Res.Pract., 1991, 187, 871-75. 
85 J.A. Bridge, D.A. Borek, J.R. Neff et al., Chromosomal 
Abnormalities in Clear Cell Sarcoma, Am.J.Clin.Path., 1990, 
..2..J, 26-31. 
86 G. Mechtersheimer, w. Tilgen, E. Klar et al., Clear Cell 
Sarcoma of Tendons & Aponeuroses: Case Presentation with 
Special Reference to IHC Findings, Hum.Path., 1989, 20, 914-7. 
87 P.E. Swanson & M.R. Wick, Clear Cell Sarcoma, 
Arch.Path.Lab.Med., 1989, 113, 55-60. 
88 A.K. El-Naggar, N.M. Ordonez, A. Sara et al., Clear Cell 
Sarcomas and Metastatic Soft Tissue Melanomas, Cancer, 1991, 
&.1..., 2173-9. 
89 A.S. Sara, H.L. Evans & R.S. Benjamin, Malignant Melanoma 
of Soft Parts, Cancer, 1990, 65, 367-74. 
90 C.A. Holden, J. Spaull, A.K. Das et al., The Histogenesis 
of Angiosarcoma of the Face and Scalp: an IHC and 
Ultrastructural Study, Histogath., 1987, 1.l, 37-51. 
108 
91 C.D.M. Fletcher, A. Beham, s. Bekir et al., Epithelioid 
Angiosarcoma of Deep Soft Tissue, Am.J.Surg.Path., 1991, .1.5., 
915-24. 
92 K.J. Smith, H.G. Skelton, W.D. James et al., Angiosarcoma 
Arising in Kaposi's Sarcoma, J.Am.Acad.Dermatol., 1991, 24, 
790-2. 
93 J.U. Alles & K. Bosslet, IHC of Angiosarcomas, 
Am.J.Clin.Path., 1988, -8..ft, 463-71. 
94 C.D.M. Fletcher, A. Beham & C. Schmid, Spindle Cell 
Haemangioendothelioma - A Clinicopathological and IHC Study 
Indicative of a Non-Neoplastic Lesion, Histopath., 1991, .l.ft, 
291-301. 
95 N. Zoltie & P.F. Roberts, Spindle Cell 
Haemangioendothelioma in Association with Epithelioid 
Haemangioendothelioma, Histopath., 1989, 15, 544-6. 
96 J. Lamovec, H.J. Sobel, A. Zidar et al., Epithelioid 
Hemangioendothelioma of the Anterior Mediastinum with 
Osteoclast-like Giant Cells, Am.J.Clin.Path., 1990, .2]., 813-7. 
97 W.Y.W. Tsang & J.K.C. Chan, Kaposi-like Infantile 
Hemangioendothelioma - a Distinctive Neoplasm of the 
Retroperitoneum, Am,J.Surg.Path., 1991, .1.5., 982-9. 
98 F. Fachetti, L. Lucini, R. Gavazzoni et al., 
Immunomorphological Analysis of the Role of Blood Vessel 
Endothelium in the Morphogenesis of Kaposi's Sarcoma, 
Histopath., 1988, 12, 581-93. 
99 B. Siegal, S. Levinton-Kriss, A. Schiffer et al., Kaposi's 
Sarcoma in Immunosuppression, Cancer, 1990, 65, 492-8. 
100 E.S.G. D'Amore, J.C. Manivel & J.H. Sung, Soft Tissue and 
Meningeal Hemangiopericytomas, Hum.Path., 1990, 2.1, 414-23. 
101 B.M. Hultberg, S. Daugaard, H.F. Johansen et al., 
Malignant Haemangiopericytomas and 
Haemangioendotheliosarcomas: an IHC Study, Histopath., 1988, 
li, 405-14 
102 J H E" hh GR D" k . AK Bh t 1 . . 1c orn, . . 1c ersinn, . . an e a . , 
Sinonasal Hemangiopericytoma, Am.J.Surg.Path., 1990, .11., 856-
66. 
103 R.R. Winek, B.W. Scheithauer & M.R. Wick, Meningioma, 
Meningeal Hemangiopericytoma, Peripheral Hemangiopericytoma 
and Acoustic Schwannoma, Am.J.Surg.Path., 1989, 13, 251-61. 
104 C. Ladefoged & N.K. Jensen, Synovial Haemangiopericytoma 
of the Knee Joint, Histopath., 1989, 15, 635-37. 
109 
105 J.T. Plukker, H.SD. Koops, I. Molenaar et al., Malignant 
hemangiopericytoma in Three Kindred Members of One Family, 
Cancer, 19188, .§.1, 841-4. 
106 E.S. Yi, B.M. Schmookler. M.M. Malawer et al., Well-
differentiated Extraskeletal Osteosarcoma - a Soft Tissue 
Homologue of Parosteal Osteosarcoma, Arch.Path.Lab.Med., 1991, 
115, 906-9. 
107 B.L. Bane, H.L. Evans, J.Y. Ro et al., Extraskeletal 
Osteosarcoma, a Clinicopathological Review of 26 Cases, 
Cancer, 1990, .QQ, 2762-70. 
108 G.R. Dickersin & A.E. Rosenberg, The Ultrastructure of 
Small-cell Osteosarcoma, with a Review of the Light Microscopy 
and Differential Diagnosis, Hum.Path., 1991, 22, 267-75. 
109 R.C. Chetty, Extraskeletal Mesenchymal Chondrosarcoma of 
the Mediastinum, Histopath., 1990, 11, 261-3. 
110 A.L. Nielsen & T. Klaer, Malignant Giant Cell Tumour of 
Synovium and Locally Destructive Pigmented Villonodular 
Synovitis, Hum.Path., 1989, 20, 765-71. 
111 A. Llombart-Bosch, J. Terrier-Lacombe, A. Peydro-Olaya et 
al., Peripheral Neuroectodermal Sarcoma of Soft Tissue, 
Hum.Path., 1989, 20, 273-80. 
112 S. Ushigome, T. Shimoda. K. Tenaki et al., IHC and US 
Studies on the Histogenesis of Ewing's Sarcoma and Putatively 
Related Tumours, Cancer, 1989, 64, 52-62. 
113 R.L. Carter, s.z. Al-Sam, R.P. Corbett et al., A 
Comparative Study of IHC Staining for NSE, PGP-9,5 and SlOO 
Protein in Neuroblastoma, Ewing's Sarcoma and Other Round Cell 
Tumours in Children, Histopath., 1990, 16, 461-7. 
114 A. Llombart-Bosch, c. Carda, A. Peydro-Olaya et al., Soft 
Tissue Ewing's Sarcoma: Characterisation in Established 
Cultures and Xenografts with Evidence of a Neuroectodermic 
Phenotype, Cancer, 1990, .QQ, 2589-601. 
115 N.P. Rud, H.M. Reiman, D.J. Pritchard et al., 
Extraosseosus Ewing's Sarcoma: A Study of 42 Cases, Cancer, 
1989, 64, 1548-53. 
116 E.J. Fellinger, P. Garinchesa, T.J. Triche et al., IHC 
Analysis of Ewing's Sarcoma Cell Surface Antigen p30/32MIC2, 
Am.J.Path., 1991, 139, 317-25. 
117 I.F. Ambros, P.F. Ambros, s. Strehl et al., MIC2 is a 
Specific Marker for Ewing's Sarcoma and Peripheral Primitive 
Neuroectodermal Tumours - Evidebce for a Common Histogenesis, 
Cancer, 1991, ~' 1886-93. 
110 
118 T-K. Chang, c.-Y. Li & W.A. Smithson, Immunocytochemical 
study of Small Round Cell Tumors in Routinely Processed 
Specimens, Arch.Path.Lab.Med., 1989, 113, 1343-8. 
119 P.Garinchesa, E.J. Fellinger, A.G. Huvos et al., IHC 
Analysis of Neural Cell Adhesion Molecules - Differential 
Expression in Small Round Cell Tumours of Childhood and 
Adolescence, Am.J.Path., 1991, 139, 275-86. 
120 N.M. Marina, E. Etcubanas, D.M. Parham et al., Peripheral 
PNET in Children, Cancer, 1989, 64, 1952-60. 
121 R.C. Schamberger, H.E. Grier, H.J. Weinstein et al., Chest 
Wall Tumours in Infancy and Childhood, Cancer, 1989, 63, 774-
85. 
122 Y. Fujii, T. Hongo, Y. Nakagawa et al., Cell Culture of 
Small Round Cell Tumour Originating in the Thoracopulmonary 
Region, cancer, 1989, 64, 43-51. 
123 F.C. Schmitt & C.E. Bacchi, SlOO Protein - Is it Useful as 
a Tumour Marker in Diagnostic IHC?, Histopath., 1988, 15, 281-
8. 
12 4 M.D. Johnson, A. Glick & B.W. Davis, IHC Evaluation of Leu-
7, MBP, SlOO, GFAP and LN3 Immunoreactivity in Nerve Sheath 
Tumors and sarcomas, Arch.Path.Med.Lab., 1988, 112, 155-60. 
125 R.A. Erlandson, The Enigmatic Perineurial Cell and its 
Participation in Tumors and Tumor-like Entities, 
UltrastructPath., 1991, 15, 335-51. 
126 J.M. Theaker & C.D.M. Fletcher, EMA Expression by the 
Perineurial Cell, Histopath., 1989, 14, 581-92, 
127 C.D.M. Fletcher, Soft Tissue Tumours - Selected Summary, 
J.Path., 1989, 159, 341-4. 
128 M.H. Gray, A.E. Rosenberg, G.R. Dickersin et al., GFAP and 
Keratin Expression by Benign and Malignant PNSTs, Hum.Path., 
1989, 20, 1089-96. 
129 P.A. Cross & N.W. Clarke, MPNST with Epithelial Elements, 
Histopath., 1988, 12, 547-61. 
1 3o C.D.M. Fletcher, S.E. Davies & P.H. McKee, Cellular 
Schwannoma: a Distinct Pseudosarcomatous Entity, Histopath., 
1987, 11, 21-35. 
131 s t · .Y. Wong, M. Teh, Y.o. Tan e al., Malignant Glandular 
Triton Tumour, Cancer, 1991, 67, 1076-83. 
111 
132 J.R. Goodlad & c.D.M. Fletcher, MPNST with Annulate 
Lamellae Mimicking Pleomorphic MFH, J.Path., 1991, .l,QA, 23-9. 
133 S.A. Rasbridge, N.L. Browse, J.R. Tighe et al., MPNST 
Arising in a Benign Ancient Schwannoma, Histopath., 1989, lA, 
525-8. 
134 D.K. Robson & J.W. Ironside, MPNST Arising in a Schwannoma, 
Hist~path., 1990, 16, 295-308. 
135 C.D.M. Fletcher, I.N. Fernando, M.V. Braimbridge et al., 
Malignant Nerve Sheath Tumour Arising in a Ganglioneuroma, 
Histopath., 1988, 12, 445-54. 
136 M.J. Newbould, N. Wilkinson & J. Mene, Post-radiation 
MPNST, Histopath., 1990, lZ, 263-5. 
137 R.H. Hruban, M.H. Shiu, R.T. Senie et al., MPNST of the 
Buttock and Lower Extremity, cancer, 1990, 66, 1253-65. 
138 D.G. O'Donovan & P. Kell, Malignant Granular Cell Tumour 
with Intraperitoneal Dissemination, Histopath., 1989, .J.A, 417-
28. 
139 s. Thunold, F.E. von Eyben & B. Maehle, Malignant Granular 
Cell Tumour of the Neck: IHC and US Studies of a Case, 
Histopath., 1989, .l.i, 655-62. 
140 D.S. Heller, C.P. Frydman, R.E. Gordon et al., An Unusual 
Tumor: ASPS or Paraganglioma?, cancer, 1991, fLl..., 1894-9. 
141 P.H. Lieberman, M.F. Brennan, M. Kimmel et al., Alveolar 
Soft Part Sarcoma, Cancer, 1989, .§.J., 1-13. 
142 M.P. Foschini, c. Ceccarelli, v. Eusebi et al., ASPS: 
Immunological Evidence for Rhabdomyoblastic Differentiation, 
Histopath., 1988, 13, 101-8. 
143 N.G. Ordonez, J.Y. Ro & B. Mackay, ASPS, an us and IHC 
Investigation of its Histogenesis, cancer, 1989, 63, 1721-36. 
1 44 M. Miettinen & T. Ekfors, ASPS: IHC Evidence for Muscle 
Cell Differentiation, Am,J.Clin.Path., 1990, 93, 32-8. 
145 T. Hirose, E. Kudo, T. Hasegawa et al., Cytoskeletal 
Properties of ASPS, Hum.Path., 1990, 2.1., 204-11. 
146 J R . p . t 1 , . osai, . Dias, D.M. Parham, e a., MyoDl Protein 
Expression in ASPS as Confirmatory Evidence of its Skeletal 
Muscle Nature, Am.J.Surg.Path., 1991, ~, 974-81. 
1 47 c. Sotelo-Avila, F. Gonzalez-crussi, s. Sadowinski et al., 
Clear cell sarcoma of the kidney, Hum.Path., 1986, 1.§., 1219-30. 
112 
148 S.I. Hajdu, Differential Diagnosis of Soft Tissue and Bone 
Tumors, Lea & Febiger, 1986. 
149 D.M. Eddy & C.H. Clanton, The Art of Diagnosis, 
New Engl.J,Med., 1982 1..Q.Q., 1263-8. 
lSO R.L. Kempson, Standardisation of the Surgical Pathology 
Report, Arn.J.Surg.Path., 1992, .l.q, 84-6. 
APPENDIX 113 
CASES INCORPORATED IN THIS STUDY AS 
ORIGINALLY DIAGNOSED 
A question mark indicates a diagnosis thought probable. 
The order is that of increasing SNOMed morphology code 
SARCOMA NOS (S = specifically reported as Spindled) 
1960 4822 5338 8897 
1961 2538 3327 3663? 3589S 3784 4409 4840 5490 6151 (vascular) 9463S? 
1962 1001 2570 3489 3887? 5679S 6043 6293 6721S 
1963 2482 5088 5698 6347S 7025? 
1964 1656S 3142 3750 7654 8433? 9633 
1971 2694 3631 3768 3815 4490? 6923S 8473 9068S 12632S 
1972 356 2912S 3451S? 11662 
1973 725? 4649 4659S 5284S 5789 
1974 11758 
1975 525 2748 12535 13591 
1976 999? 2897? 3936 5438 5576 9392S 13275? 13318S? 
1977 8608S 9789S 10267 15136 
1978 5265 6058 12447S 12968 
1980 4432? 
1981 4889 12196S 15015S 
1982 1952? 7393 10137S 11915 16097S? 
1986 2027 3491S 4412 5511? 12945 
1987 8845? 9076? 10485 13095 16150 16813 
1988 2236 2774? 5376? 5955S 7337? 8951 10239 13723 
1989 7869 10083? 













1960 6882? 7734 8576 
1961 2775 5468 7749 9054 
1962 8084 
1963 1722 2343 7560 
1964 none 
(Fibrosarcoma contd) 
1971 5418 5945? 
114 
1972 6081? 8154? 9230? 11260? 
1973 61? 6325 8696 10272 
1974 10581? 13359 
1975 12821 
1976 none 
1977 3636 14312 
1978 420 4800? 10767 11317? 





MALIGNANT FIBROUS HISTIOCYTOMA (H) 
MALIGNANT FIBROXANTHOMA (X) 
1960-4 not applicable 
1971-2 none 
1973 2084X? 5847X 
1974 4573X 8428X 11447X 13236X 
1975 3956X? 4031X? 11321X? 11804X 12167X 
1976 12267X 
1977 2142X 7386H 11006H 12502X 
1978 1445H 7317H? 
1980 3500H 3555H 12744H 
1981 llOOX 8781H 15249H 
1982 3013H 8166H 13595H? 15930H 
1986 1451H 7058H? 8082H? 17336H? 
1987 5350H 9296H? 9424H 9598H 14195H 
1988 7593H? 10456H 13739? 18171H 18819H 
1989 1588H 2483H? 3176H 3898H 4620H 7615H 7929H 8888H 13339H 13444H 
1990 729H 730H 2944H 12951H 15496H? 
DERMATOFIBROSARCOKA PROTUBERANS 
1960 none 





1973 65? 110 1780 7088 7328 8943 
1974 3061 
1975,6 none 
1977 2192 13188? 





















LIPOSARCOKA (H = myxoid, P = pleomorphic, R = round-cell, S = sclerosing, 
W = 1ell differentiated, ; = mixed) 
1960 none 
1961 5694? 
1962 3470 5921 5997 
1963 none 
1964 [3828, vide 6567, case unassessable] 6869? 
1971 3075M 4395W 10842W 
1972 927W 4197M 7698P 9125P 
1973 1056W 3349# 8645H 9053 W 
1974 2819W 3267M 3341K 8174P 9426WS 13360 
1975 3157WS 3562K 3996W 46641( 6698W 9252R 12752W 13057W 130661( 
1976 1285K 1459K 2076W 2383W 3563K 54561{ 6822 10095W 11378K 
1977 846W 1271W 2950 5647K 6514 10176W 
1978 1870K 4347K? 5284K 
1980 2781PS 3557 4245# 8988P 
1981 6026K 8644S? 9416K 
1982 none 
1986 3793K 12278P 
1987 43011{ 4810W 15331P 






1964 5581 8906 
115 
13100W 13291P 









1981 1557 4982 6506 
1982 8963 
1986 13371 14104 
1987 5960? 9420? 
1988 1820 3343 4867 12494 
1989 438 
1990 none 






1971 2532A 2761B 5442B? 10207P 
1972 11048E 
1973 4402B 5826? 8152E 8328P 12580P 
1974 1680 9141E 
1975 8198P 10129 11703E 12970P 
1976 1354E 2226E 
1977 13293? 
1978 1600E 3510 10366E 
1980 1010A 11325? 
1981 none 
1982 4156P 7739 11680B 
1986 4996E 
1987 4962A 8555? 10069A 17412EP 
1988 5326 15579E 
1989 9602 16210 



















1973 8691 10169B 
1974 4880B 6740B 
1975 12298B? 
1976 6976B 10398? 
1977 6889K 
1978 10486B 11002B? 
1980 8903K 15983K 
1981 16398B 
1982 9227Jf? 12187H? 
1986 4883K 6776)[ 
1987 1011 
1988 9899K 
1989 71? 13099B 
1990 6384 68861{ 
CLEAR CELL SARCOMA 






















(Angiosarcoma contd) 118 
1980 none 
1981 14287 
1982 9337 14699 
1986 none 
1987 300 10328? 11648 











1963 284? 1887? 
1964 8172 
1971 5099 
1972 8163 9397 9699 11517 
1973 6802 10254 
1974 none 
1975 10023 10653 12390? 
1976 6388 9956 10137 10206 13722 
1977 1184? 
1978 2641 7179 9883 13693 
1980 842 6753? 16227 
1981 11235 14472? 
1982 1009? 1299 7437 15146 
1986 11314 13762 
1987 1323 2846 11035 
1988 2982 6289 6763 7265 13714 14209 16914? 
1989 7094 11996 

































1978 3440 8678 
1980-2 none 
1986-90 none 





(Extraskeletal Ewing 1s Sarcoma contd) 
1986-7 none 
1988 11827 8840 
1989 9058 13280 
1990 none 
MALIGNANT PERIPHERAL NERVE SHEATH TUHOUR 
(N = neurofibrosarcoma, S = Malignant SChwannoma, 
T = Triton (i.e. rhabdomyoblastic differentiation.) 
1960 13284N? 
1961 89? 3022? 
1962 292S 
1963 18178N? 5412N 
1964 none 
1971 7793N 11045N? 
1972 6168N 
1973 1492N 3789S? 9170N? 
1974 4504N 9636? 11196S? 
1975 4385S 
1976 426N 675N 
1977 none 
1978 3439N 5870S 
1980 ll083S 
1981 none 
1982 609 11196 
1986 715S 8887N 18014 
1987 9808 
1988 554N 1286T l1038N? 
1989 12516N 12930S 
1990 4661S 5070N 









ALVEOLAR SOFT PART SARCOMA 121 
1960-1 none 
1962 953 8072 
1963-4 none 
1971-3 none 
1974 1524 
1975-6 none 
1977 1219 
1978 none 
1980 9283 
1981-2 none 
1986-90 none 
